ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

/ ISO 80601-2-72:2015 basic safety or essential performance of the ventilator, New Standard Certifications / By

ISO 80601-2-72:2015 – Basic Safety and Essential Performance of Ventilators

ISO 80601-2-72:2015 is an international standard that outlines the requirements for the basic safety and essential performance of ventilators used for medical purposes. It is part of the broader ISO 80601 series, which focuses on the safety and effectiveness of medical electrical equipment.

Key Aspects of ISO 80601-2-72:2015

  1. Scope:
    • The standard applies specifically to ventilators intended for use in various healthcare settings, including hospitals, clinics, and home care.
    • It covers ventilators that provide respiratory support, including invasive and non-invasive ventilation.
  2. Basic Safety:
    • Basic safety refers to the protection of patients and users from harm during the use of the ventilator. This includes the identification and mitigation of hazards associated with the equipment.
    • Requirements include:
      • Electrical safety to prevent electrical shocks.
      • Mechanical safety to prevent injuries from moving parts or heavy weights.
      • Environmental safety to ensure that the device operates effectively under varying environmental conditions (temperature, humidity, etc.).
  3. Essential Performance:
    • Essential performance pertains to the performance of the ventilator necessary to achieve the intended use, ensuring that it operates effectively and reliably.
    • Key performance requirements include:
      • Accurate monitoring and control of respiratory parameters (e.g., tidal volume, pressure, and flow).
      • Response to patient needs and alarms in a timely manner.
      • Adequate backup systems to maintain ventilation in case of power failure or equipment malfunction.
  4. Risk Management:
    • The standard emphasizes a risk management approach, requiring manufacturers to assess and manage risks throughout the product lifecycle, including design, manufacturing, and post-market surveillance.
    • Manufacturers must implement measures to minimize risks related to the use of ventilators, including user training and maintenance protocols.
  5. Testing and Verification:
    • Ventilators must undergo rigorous testing to ensure compliance with the requirements set forth in the standard.
    • Testing should cover safety and performance aspects, including:
      • Electrical and mechanical safety tests.
      • Functional tests to verify that the ventilator performs as intended under various conditions.
      • Tests for alarm systems to ensure that they provide timely and effective notifications.
  6. Documentation and Labeling:
    • Manufacturers are required to maintain comprehensive documentation demonstrating compliance with the standard.
    • This includes user manuals, technical specifications, and labels that inform users about safety and performance features.
  7. Regulatory Compliance:
    • Compliance with ISO 80601-2-72:2015 is often necessary for regulatory approvals in various markets, as it provides a recognized framework for ensuring the safety and performance of ventilators.

Conclusion

ISO 80601-2-72:2015 is essential for ensuring that ventilators used in medical settings are safe and effective. By adhering to the requirements outlined in this standard, manufacturers can mitigate risks associated with ventilator use, enhance patient safety, and support healthcare providers in delivering high-quality respiratory care. Compliance with this standard also aids in gaining regulatory approval, facilitating market access for medical ventilators.

What is required ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

Requirements of ISO 80601-2-72:2015 for Basic Safety and Essential Performance of Ventilators

ISO 80601-2-72:2015 outlines specific requirements to ensure the basic safety and essential performance of ventilators. Here’s a detailed breakdown of the key requirements under this standard:

1. General Requirements

  • The standard specifies general requirements for the basic safety and essential performance of ventilators used for medical purposes, including those used in hospitals, home care, and emergency settings.

2. Basic Safety Requirements

  • Electrical Safety:
    • Compliance with electrical safety standards to prevent electric shock or fire hazards.
    • Proper insulation, grounding, and fuses to protect users and patients.
  • Mechanical Safety:
    • Design considerations to avoid mechanical hazards, such as pinch points, sharp edges, or heavy components that could cause injury.
    • Robustness against mechanical stresses and environmental factors.
  • Environmental Safety:
    • Ability to operate safely in various environmental conditions, including temperature and humidity limits.
    • Protection against ingress of water and dust (IP rating).
  • Materials Safety:
    • Use of biocompatible materials for any components that may come into contact with patients or their fluids.
    • Resistance to degradation over time to ensure continued safety and effectiveness.

3. Essential Performance Requirements

  • Performance Monitoring:
    • Accurate monitoring of vital respiratory parameters (e.g., tidal volume, pressure, flow rate).
    • Real-time display of monitored parameters for healthcare providers.
  • Alarms and Notifications:
    • Effective alarm systems to alert users to critical conditions, such as low battery, circuit failures, or changes in patient status.
    • Alarm thresholds must be adjustable and appropriate for the patient population being served.
  • Respiratory Support Functions:
    • Capability to deliver specific modes of ventilation (e.g., volume control, pressure control) as per the clinical needs.
    • Consistency in performance under varying loads and conditions to ensure reliable respiratory support.
  • Backup Systems:
    • Implementation of backup systems (e.g., battery power) to maintain ventilation during power failures or equipment malfunctions.
    • Fail-safe mechanisms to ensure that the device continues to function within specified parameters.

4. Risk Management

  • Risk Assessment:
    • Conduct a comprehensive risk assessment throughout the product lifecycle to identify potential hazards and implement mitigation strategies.
    • Compliance with ISO 14971 (Risk management for medical devices) is often necessary.
  • Post-Market Surveillance:
    • Establishing mechanisms for monitoring the performance and safety of the ventilator after it has been marketed, including gathering user feedback and addressing reported issues.

5. Testing and Verification

  • Performance Testing:
    • Conduct tests to verify that the ventilator meets specified performance characteristics.
    • Regular maintenance and recalibration of equipment to ensure ongoing compliance with safety and performance requirements.
  • Documentation of Testing:
    • Maintain detailed records of all testing performed, including methodologies, results, and any corrective actions taken.

6. Documentation and Labeling

  • User Manuals:
    • Provide clear and comprehensive user manuals that include safety information, operational instructions, and troubleshooting guidance.
  • Labeling:
    • Labels must convey critical information regarding the ventilator’s intended use, safety instructions, and performance specifications.
  • Technical Files:
    • Maintain a technical file that includes design, manufacturing, and quality assurance information to demonstrate compliance with the standard.

7. Regulatory Compliance

  • Compliance with ISO 80601-2-72:2015 is essential for meeting regulatory requirements in various jurisdictions, facilitating market access and acceptance by healthcare institutions.

Conclusion

ISO 80601-2-72:2015 sets forth comprehensive requirements to ensure the basic safety and essential performance of ventilators. By adhering to these requirements, manufacturers can provide reliable and safe respiratory support devices that meet regulatory standards and contribute positively to patient care in various medical settings. Compliance with this standard not only protects patients and healthcare providers but also enhances the credibility and marketability of ventilator products.

Who is required ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

ISO 80601-2-72:2015 applies to various stakeholders involved in the manufacturing, regulation, and use of medical ventilators. Here’s a breakdown of who is required to comply with this standard:

1. Manufacturers of Ventilators

  • Design and Production: Manufacturers who design, develop, and produce ventilators intended for medical use must comply with the requirements outlined in the standard to ensure safety and performance.
  • Quality Management: Manufacturers are typically required to implement a quality management system (QMS) that aligns with ISO 13485, which covers the design and manufacture of medical devices.

2. Suppliers and Component Manufacturers

  • Material Compliance: Suppliers providing components, materials, or subsystems used in ventilators must ensure that their products meet the safety and performance criteria set forth in ISO 80601-2-72:2015.
  • Documentation: Suppliers are also responsible for providing appropriate documentation, including material safety data sheets (MSDS) and declarations of conformity.

3. Regulatory Authorities

  • Approval and Oversight: Regulatory bodies (such as the FDA in the United States or the European Medicines Agency in Europe) require compliance with ISO 80601-2-72:2015 as part of the evaluation process for obtaining market authorization for ventilators.
  • Standard Enforcement: Regulatory authorities may reference this standard in their guidelines to ensure that medical devices meet necessary safety and effectiveness criteria.

4. Healthcare Facilities

  • Procurement and Use: Hospitals and healthcare organizations that procure and utilize ventilators are indirectly affected by this standard. They must ensure that the devices they acquire are compliant with relevant safety and performance standards to protect patients.
  • Training and Protocols: Healthcare providers must implement training protocols for staff to ensure proper use of the ventilators in line with the manufacturer’s guidelines.

5. Quality Assurance and Testing Laboratories

  • Testing and Certification: Independent testing laboratories that evaluate the safety and performance of ventilators may use ISO 80601-2-72:2015 as a reference standard during their certification and testing processes.
  • Conformance Verification: These laboratories play a critical role in verifying compliance with the standard through rigorous testing protocols.

6. Distributors and Importers

  • Market Compliance: Distributors and importers of ventilators must ensure that the products they bring to market comply with ISO 80601-2-72:2015 and any applicable regulations in the countries where they operate.
  • Product Traceability: They should maintain records of compliance documentation to facilitate traceability and accountability.

Conclusion

ISO 80601-2-72:2015 is a critical standard that affects a wide range of stakeholders in the medical ventilator industry, from manufacturers and suppliers to regulatory authorities and healthcare providers. Compliance with this standard is essential for ensuring the safety, effectiveness, and regulatory acceptance of ventilators in various healthcare settings, ultimately contributing to improved patient care and outcomes.

When is required ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

ISO 80601-2-72:2015 is required in several key scenarios related to the manufacturing, regulation, and utilization of medical ventilators. Here’s an overview of when compliance with this standard is necessary:

1. During Product Development

  • Design Phase: Manufacturers are required to adhere to ISO 80601-2-72:2015 during the design and development of ventilators. This ensures that safety and performance are integrated into the product from the outset.
  • Risk Management: As part of the design process, manufacturers must conduct risk assessments and implement risk management strategies in accordance with the standard.

2. Before Market Introduction

  • Regulatory Approval: Compliance with ISO 80601-2-72:2015 is typically required for obtaining regulatory approvals before a ventilator can be marketed. Regulatory authorities reference this standard to assess the safety and effectiveness of the device.
  • Certification Processes: Manufacturers may need to demonstrate compliance through testing and certification processes conducted by notified bodies or independent testing laboratories.

3. In Quality Management Systems

  • Quality Assurance: Manufacturers that implement a quality management system (QMS), such as ISO 13485, are required to integrate the requirements of ISO 80601-2-72:2015 into their processes to ensure ongoing safety and effectiveness.
  • Continuous Monitoring: Organizations must regularly evaluate their products against this standard as part of their continuous quality improvement processes.

4. During Production and Testing

  • Manufacturing Compliance: ISO 80601-2-72:2015 requirements must be met during the manufacturing process to ensure that all safety and performance criteria are satisfied.
  • Verification and Validation: Testing must be performed to verify that the ventilators conform to the specifications outlined in the standard, ensuring that they meet essential performance and safety requirements.

5. Post-Market Surveillance

  • Monitoring and Reporting: After the ventilators are on the market, manufacturers are required to continue monitoring their products for compliance with ISO 80601-2-72:2015. This includes addressing any safety issues or adverse events that arise.
  • Periodic Reviews: Regular assessments and audits of the product’s performance and safety features must be conducted to ensure ongoing compliance.

6. When Upgrading or Modifying Devices

  • Design Changes: If a manufacturer makes significant design changes or introduces new features to an existing ventilator, they must reassess compliance with ISO 80601-2-72:2015.
  • Regulatory Notifications: Regulatory authorities may require manufacturers to submit updates or modifications based on compliance with the standard whenever substantial changes are made.

7. For Training and Operational Protocols

  • Healthcare Provider Training: Healthcare facilities must ensure that staff are trained on the proper use of ventilators according to the guidelines provided by ISO 80601-2-72:2015 to mitigate risks associated with their operation.
  • Standard Operating Procedures (SOPs): Development of SOPs for ventilator operation, maintenance, and troubleshooting should be aligned with the requirements of the standard.

Conclusion

ISO 80601-2-72:2015 is required at multiple stages in the lifecycle of medical ventilators, from design and development through to market introduction and post-market surveillance. Compliance with this standard is essential for ensuring that ventilators are safe, effective, and suitable for patient care in various healthcare settings.

Where is required ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

ISO 80601-2-72:2015 is required in various contexts related to the design, manufacturing, and usage of medical ventilators. Here’s a detailed overview of where compliance with this standard is necessary:

1. Healthcare Facilities

  • Hospitals and Clinics: Medical ventilators used in hospitals and outpatient clinics must comply with ISO 80601-2-72:2015 to ensure patient safety and effective treatment.
  • Intensive Care Units (ICUs): In critical care settings, where ventilators are essential for patient management, compliance with this standard is particularly crucial.
  • Emergency Medical Services (EMS): Ventilators used in ambulances and emergency response vehicles must meet this standard to ensure safety and reliability during transport.

2. Manufacturing Sites

  • Ventilator Production Facilities: Manufacturers of medical ventilators are required to implement ISO 80601-2-72:2015 at their manufacturing plants to ensure that products meet necessary safety and performance specifications.
  • Component Manufacturing: Suppliers and manufacturers of components used in ventilators (such as sensors, valves, and circuitry) must also comply with this standard, ensuring the quality and safety of the parts they supply.

3. Regulatory and Certification Bodies

  • Notified Bodies and Auditors: Organizations that assess and certify compliance with medical device regulations, including ISO 80601-2-72:2015, play a critical role in ensuring that ventilators meet required standards before they can be marketed.
  • Regulatory Authorities: National and international regulatory bodies (such as the U.S. FDA or European Medicines Agency) reference ISO 80601-2-72:2015 when evaluating medical devices for safety and efficacy.

4. Research and Development Laboratories

  • Testing and Validation Labs: Laboratories involved in testing the performance and safety of medical devices, including ventilators, must adhere to the requirements of ISO 80601-2-72:2015 during their evaluation processes.
  • Prototype Development: Organizations developing new ventilator technologies must consider this standard in their research and development processes to ensure that new devices are safe and effective.

5. Quality Management Systems (QMS)

  • Medical Device Manufacturers: Manufacturers who implement a quality management system based on ISO 13485 are required to integrate the requirements of ISO 80601-2-72:2015 into their QMS to ensure ongoing compliance and safety of their products.
  • Internal Auditors: Organizations must have internal auditors trained to evaluate compliance with ISO 80601-2-72:2015 as part of their quality assurance processes.

6. Training and Education Programs

  • Healthcare Provider Training: Medical institutions must ensure that training programs for healthcare providers include information on the safe and effective use of ventilators compliant with ISO 80601-2-72:2015.
  • Continuing Education: Ongoing education programs for clinical staff may also incorporate aspects of this standard to ensure staff are updated on best practices and safety protocols.

7. Maintenance and Servicing Facilities

  • Medical Equipment Servicing: Facilities that provide maintenance, repair, and servicing for ventilators are required to follow ISO 80601-2-72:2015 to ensure that any servicing performed maintains the safety and performance of the device.
  • Calibration Services: Organizations that calibrate ventilators must ensure that their processes align with the standard to ensure accurate performance and safety.

Conclusion

ISO 80601-2-72:2015 is required in various environments, including healthcare facilities, manufacturing sites, regulatory bodies, and training programs. Compliance with this standard is essential for ensuring the safety and effectiveness of medical ventilators across diverse applications in patient care and treatment.

How is required ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

ISO 80601-2-72:2015 specifies the requirements for the basic safety and essential performance of ventilators. Compliance with this standard is achieved through a combination of design, testing, documentation, and continuous monitoring. Here’s a detailed overview of how the requirements are implemented:

1. Design and Development Process

  • Risk Management: Manufacturers must implement a risk management process in line with ISO 14971, which includes identifying hazards, assessing risks, and implementing controls to mitigate those risks throughout the ventilator’s lifecycle.
  • Safety Features: The design must incorporate safety features that prevent or reduce potential hazards. This includes alarms for malfunctions, mechanisms for safe operation during power failures, and safeguards against improper use.

2. Testing and Verification

  • Performance Testing: Ventilators must undergo rigorous performance testing to ensure they meet the specified requirements for functionality, safety, and effectiveness. This includes evaluating the ventilator’s ability to deliver the correct tidal volume, pressure, and flow rate.
  • Electrical Safety Testing: Compliance with electrical safety standards (such as IEC 60601-1) is required to ensure the ventilator is safe for use, preventing risks related to electrical shock or fire.
  • Environmental Testing: Testing under various environmental conditions (temperature, humidity, etc.) is necessary to ensure reliable performance in real-world conditions.

3. Documentation and Records

  • Technical Documentation: Manufacturers must maintain comprehensive technical documentation that demonstrates compliance with ISO 80601-2-72:2015. This includes design specifications, testing protocols, and results.
  • User Manuals: Clear and informative user manuals must be provided to ensure that healthcare providers understand how to safely operate and maintain the ventilators.

4. Quality Management System (QMS) Implementation

  • ISO 13485 Compliance: Manufacturers are required to establish and maintain a quality management system that adheres to ISO 13485, which governs the design, development, production, and post-market activities for medical devices.
  • Process Control: The QMS must include controls for design changes, manufacturing processes, supplier management, and corrective actions to address non-conformities.

5. Regulatory Approval and Certification

  • Pre-Market Approval: Before a ventilator can be marketed, it must undergo evaluation by regulatory authorities (such as the FDA or EMA), which may involve demonstrating compliance with ISO 80601-2-72:2015 through testing and documentation.
  • Notified Body Review: If applicable, manufacturers must submit their products to a notified body for review and certification, ensuring compliance with relevant medical device regulations.

6. Post-Market Surveillance

  • Monitoring Performance: After the ventilators are on the market, manufacturers must implement post-market surveillance activities to monitor product performance, collect feedback, and identify any safety concerns.
  • Adverse Event Reporting: Manufacturers are required to report any adverse events or safety issues to regulatory authorities in accordance with local regulations.

7. Training and Education

  • Staff Training: Healthcare facilities must provide training to staff on the proper use and maintenance of ventilators. Training programs should be aligned with the safety and performance standards outlined in ISO 80601-2-72:2015.
  • Competency Assessments: Ongoing competency assessments may be conducted to ensure that healthcare providers remain proficient in operating the ventilators safely.

Conclusion

Compliance with ISO 80601-2-72:2015 is achieved through a structured approach that includes risk management, rigorous testing, comprehensive documentation, adherence to a quality management system, regulatory approval, post-market surveillance, and staff training. These elements collectively ensure that ventilators meet the necessary safety and performance standards to protect patients and support effective medical care.

Case Study on ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

Case Study: Compliance with ISO 80601-2-72:2015 in the Development of a New Medical Ventilator

Background

A medical device manufacturer, RespiraTech, aimed to design and produce a new ventilator model, VentoPro, targeting hospitals and intensive care units (ICUs). Given the increasing demand for reliable ventilators, especially highlighted during health crises, RespiraTech recognized the importance of adhering to international safety and performance standards. The company committed to complying with ISO 80601-2-72:2015 to ensure the safety and effectiveness of VentoPro.

Objectives

  1. To design a ventilator that meets the essential performance requirements outlined in ISO 80601-2-72:2015.
  2. To establish a risk management process that identifies and mitigates potential hazards.
  3. To obtain necessary regulatory approvals before launching the product.

Implementation Steps

  1. Risk Management Plan
    • RespiraTech initiated a risk management process aligned with ISO 14971. The team conducted a hazard analysis to identify potential risks associated with the ventilator, such as:
      • Malfunctioning due to power failure.
      • Incorrect pressure delivery.
      • User errors during operation.
    • Controls were implemented, including redundant systems for critical functions and user interface designs to minimize errors.
  2. Design and Development
    • The VentoPro was designed with multiple safety features, such as:
      • Alarms: Alerts for high and low-pressure conditions.
      • Backup Systems: Battery backup for power outages.
      • User Interface: Intuitive controls that provide clear instructions and feedback.
    • Prototypes were developed, and performance testing was conducted to verify compliance with essential performance specifications.
  3. Testing and Validation
    • Rigorous testing protocols were established, including:
      • Functional Testing: Assessing the ventilator’s ability to deliver accurate tidal volumes and pressures.
      • Electrical Safety Testing: Ensuring compliance with IEC 60601-1 for electrical safety.
      • Environmental Testing: Evaluating performance under varying temperature and humidity conditions.
    • All test results were documented to create a comprehensive technical file.
  4. Quality Management System (QMS)
    • RespiraTech implemented an ISO 13485-compliant QMS that governed:
      • Design controls, including change management.
      • Supplier management for critical components.
      • Internal audits to ensure adherence to quality processes.
    • Training programs for staff were developed to ensure everyone understood the importance of maintaining quality and safety standards.
  5. Regulatory Approval
    • The completed technical documentation and risk management file were submitted to the relevant regulatory bodies (e.g., FDA and European Medicines Agency).
    • The VentoPro underwent a thorough review process, including inspections by notified bodies to assess compliance with ISO 80601-2-72:2015.
  6. Post-Market Surveillance
    • After the successful launch of VentoPro, RespiraTech established a post-market surveillance system to monitor the product’s performance in real-world settings.
    • Feedback from healthcare providers was collected to identify any issues, leading to potential enhancements in future models.

Outcomes

  • Successful Certification: VentoPro received necessary regulatory approvals and was launched in multiple markets, demonstrating compliance with ISO 80601-2-72:2015.
  • Enhanced Safety and Performance: The ventilator featured robust safety mechanisms, leading to a significant reduction in reported adverse events.
  • Positive Market Reception: Healthcare providers praised the VentoPro for its reliability, user-friendly interface, and performance, resulting in high adoption rates in hospitals and ICUs.

Conclusion

The case of RespiraTech’s VentoPro demonstrates the importance of adhering to ISO 80601-2-72:2015 in the development of medical ventilators. By implementing a structured approach to risk management, design, testing, and quality assurance, the company not only ensured the safety and effectiveness of its product but also established a foundation for ongoing compliance and improvement in its medical device offerings. This case underscores the critical role of international standards in enhancing patient safety and fostering innovation in the healthcare industry.

White Paper on ISO 80601-2-72:2015 basic safety or essential performance of the ventilator

White Paper on ISO 80601-2-72:2015: Basic Safety and Essential Performance of Ventilators

Executive Summary

ISO 80601-2-72:2015 is a pivotal international standard that outlines the basic safety and essential performance requirements for ventilators. With the increasing demand for mechanical ventilation in clinical settings, especially during public health emergencies, adherence to this standard is critical for manufacturers, healthcare providers, and regulatory bodies. This white paper provides an overview of the standard, its significance, implementation strategies, and the implications for the medical device industry.

Introduction

Mechanical ventilators are vital medical devices used to support patients with compromised respiratory function. The safety and effectiveness of these devices are paramount, given their direct impact on patient outcomes. ISO 80601-2-72:2015 specifies the requirements for the safety and performance of ventilators, providing a framework for manufacturers to ensure their products meet stringent safety standards.

Objectives of the Standard

The primary objectives of ISO 80601-2-72:2015 include:

  • Ensuring the safety and reliability of ventilators.
  • Establishing a common framework for the design, testing, and evaluation of ventilators.
  • Reducing risks associated with ventilatory support in clinical settings.
  • Enhancing the overall quality of care provided to patients requiring mechanical ventilation.

Scope of ISO 80601-2-72:2015

ISO 80601-2-72:2015 applies to ventilators used in various healthcare settings, including hospitals, emergency medical services, and home care environments. It encompasses:

  • Adult, pediatric, and neonatal ventilators.
  • Continuous positive airway pressure (CPAP) devices.
  • Bi-level positive airway pressure (BiPAP) devices.

Key Requirements

The standard outlines several critical requirements, including:

  1. Basic Safety Requirements
    • Electrical safety: Compliance with IEC 60601-1 to mitigate risks of electrical shock.
    • Mechanical safety: Ensuring the structural integrity of the device and its components.
    • Environmental safety: Performance under varying environmental conditions, such as temperature and humidity.
  2. Essential Performance Requirements
    • Accurate delivery of tidal volume, pressure, and oxygen concentration.
    • Functionality of alarms and monitoring systems to alert users to malfunctions.
    • User interface design to prevent operator errors.
  3. Risk Management
    • Implementation of a risk management process in accordance with ISO 14971, identifying hazards, assessing risks, and establishing controls to mitigate those risks.
  4. Testing and Validation
    • Comprehensive testing protocols to validate the safety and performance of the ventilator, including functional testing, performance evaluation, and reliability assessments.

Implementation Strategies

To comply with ISO 80601-2-72:2015, manufacturers should consider the following strategies:

  1. Risk Management Framework
    • Develop a robust risk management plan early in the product development process, focusing on identifying potential hazards and implementing controls.
  2. Quality Management System
    • Implement an ISO 13485-compliant quality management system to oversee design controls, manufacturing processes, and post-market surveillance.
  3. Design Controls
    • Incorporate safety features during the design phase, such as alarms for high and low-pressure conditions and user-friendly interfaces.
  4. Testing Protocols
    • Establish comprehensive testing protocols that encompass electrical safety, functional performance, and environmental conditions.
  5. Regulatory Compliance
    • Collaborate with regulatory bodies to ensure adherence to local and international regulations governing medical devices.

Implications for the Medical Device Industry

The adoption of ISO 80601-2-72:2015 has far-reaching implications for the medical device industry:

  • Enhanced Patient Safety: By adhering to the standard, manufacturers can significantly reduce risks associated with ventilatory support, leading to improved patient safety and outcomes.
  • Market Competitiveness: Compliance with recognized international standards enhances a manufacturer’s credibility and competitiveness in the global market.
  • Regulatory Approval: Meeting the requirements of ISO 80601-2-72:2015 can facilitate smoother regulatory approval processes and faster time-to-market for new ventilators.
  • Continuous Improvement: The standard encourages ongoing assessment and improvement of safety and performance, fostering innovation in ventilator design and functionality.

Conclusion

ISO 80601-2-72:2015 is a crucial standard that ensures the basic safety and essential performance of ventilators. Its implementation is vital for manufacturers aiming to deliver high-quality, safe, and effective respiratory support devices. As the healthcare landscape continues to evolve, adherence to this standard will play an essential role in enhancing patient care and safety in mechanical ventilation. By prioritizing compliance with ISO 80601-2-72:2015, the medical device industry can contribute to better health outcomes and foster trust among healthcare providers and patients alike.

References

  1. International Organization for Standardization (ISO). (2015). ISO 80601-2-72:2015 – Medical electrical equipment — Part 2-72: Particular requirements for the basic safety and essential performance of ventilators for medical use.
  2. International Electrotechnical Commission (IEC). (2012). IEC 60601-1 – Medical electrical equipment – Part 1: General requirements for basic safety and essential performance.
  3. International Organization for Standardization (ISO). (2009). ISO 14971 – Medical devices – Application of risk management to medical devices.
  4. International Organization for Standardization (ISO). (2016). ISO 13485 – Medical devices – Quality management systems – Requirements for regulatory purposes.
  5.  “Definition of label | Dictionary.com”. www.dictionary.com.
  6. ^ The American Oxonian, Volume 86, pp184. Association of American Rhodes Scholars. 1999.
  7. ^ Jump up to:a b c d e f g h Louis Rosenfeld; Peter Morville; Jorge Arango (2015). Information Architecture for the web and beyond. O’Reilly Media, Inc. ISBN 978-1-4919-1168-6.
  8. ^ Bunge, Mario (1967). Scientific research Volume II The search for truth. New York: Springer-Verlag. p. 9.
  9. ^ Bunge, Mario (1967). Scientific research Volume II The search for truth. New York: Springer-Verlag. p. 10.
  10.  “back•up”. The American Heritage Dictionary of the English Language. Houghton Mifflin Harcourt. 2018. Retrieved 9 May 2018.
  11. ^ S. Nelson (2011). “Chapter 1: Introduction to Backup and Recovery”. Pro Data Backup and Recovery. Apress. pp. 1–16. ISBN 978-1-4302-2663-5. Retrieved 8 May 2018.
  12. ^ Cougias, D.J.; Heiberger, E.L.; Koop, K. (2003). “Chapter 1: What’s a Disaster Without a Recovery?”. The Backup Book: Disaster Recovery from Desktop to Data Center. Network Frontiers. pp. 1–14. ISBN 0-9729039-0-9.
  13. ^ Jump up to:a b c Joe Kissell (2007). Take Control of Mac OS X Backups (PDF) (Version 2.0 ed.). Ithaca, NY: TidBITS Electronic Publishing. pp. 18–20 (“The Archive”, meaning information repository, including versioning), 24 (client-server), 82–83 (archive file), 112–114 (Off-site storage backup rotation scheme), 126–141 (old Retrospect terminology and GUI—still used in Windows variant), 165 (client-server), 128 (subvolume—later renamed Favorite Folder in Macintosh variant). ISBN 978-0-9759503-0-2. Archived from the original (PDF) on 1 December 2020. Retrieved 17 May 2019.
  14. ^ Ensuring the complete destruction of the primary site will not result in the loss of the recovery site by locating them physically far away.
    “.ORG Sponsorship Proposal – Technical Plan – Physical Security”. ICANN.
  15. ^ Terry Sullivan (11 January 2018). “A Beginner’s Guide to Backing Up Photos”. The New York Times. a hard drive … an established company … declared bankruptcy … where many … had …
  16. ^ McMahon, Mary (1 April 2019). “What Is an Information Repository?”. wiseGEEK. Conjecture Corporation. Retrieved 8 May 2019. In the sense of an approach to data management, an information repository is a secondary storage space for data.
  17. ^ Jeph Preece. “Online Data Backup Reviews: Why Use an Online Data Backup Service?”. Top Ten Reviews. 2016.
  18. ^ Kyle Chin. “How to Back Up Your Data: 6 Effective Strategies to Prevent Data Loss”. 2024.
  19. ^ “How do you backup your computer? Windows and Mac drive backup”. 2023.
  20. ^ Scott Gilbertson. “How to Back Up Your Digital Life”. 2024.
  21. ^ “Five key questions to ask about your backup solution”. sysgen.ca. 23 March 2014. Does your company have a low tolerance to longer “data access outages” and/or would you like to minimize the time your company may be without its data?. Archived from the original on 4 March 2016. Retrieved 23 September 2015.
  22. ^ “Incremental Backup”. Tech-FAQ. Independent Media. 13 June 2005. Archived from the original on 21 June 2016. Retrieved 10 March 2006.
  23. ^ Pond, James (31 August 2013). “How Time Machine Works its Magic”. Apple OSX and Time Machine Tips. baligu.com. File System Event Store, Hard Links. Archived from the original on 21 June 2019. Retrieved 19 May 2019.
  24. ^ Jump up to:a b Behzad Behtash (6 May 2010). “Why Continuous Data Protection’s Getting More Practical”. Disaster recovery/business continuity. InformationWeek. Retrieved 12 November 2011. A true CDP approach should capture all data writes, thus continuously backing up data and eliminating backup windows…. CDP is the gold standard—the most comprehensive and advanced data protection. But “near CDP” technologies can deliver enough protection for many companies with less complexity and cost. For example, snapshots can provide a reasonable near-CDP-level of protection for file shares, letting users directly access data on the file share at regular intervals–say, every half-hour or 15 minutes. That’s certainly a higher level of protection than tape-based or disk-based nightly backups and may be all you need.
  25. ^ Jump up to:a b “Continuous data protection (CDP) explained: True CDP vs near-CDP”. ComputerWeekly.com. TechTarget. July 2010. Retrieved 22 June 2019. … copies data from a source to a target. True CDP does this every time a change is made, while so-called near-CDP does this at pre-set time intervals. Near-CDP is effectively the same as snapshotting….True CDP systems record every write and copy them to the target where all changes are stored in a log. [new paragraph] By contrast, near-CDP/snapshot systems copy files in a straightforward manner but require applications to be quiesced and made ready for backup, either via the application’s backup mode or using, for example, Microsoft’s Volume Shadow Copy Services (VSS).
  26. ^ Pond, James (31 August 2013). “How Time Machine Works its Magic”. Apple OSX and Time Machine Tips. Baligu.com (as mirrored after James Pond died in 2013). Retrieved 10 July 2019. The File System Event Store is a hidden log that OSX keeps on each HFS+ formatted disk/partition of changes made to the data on it. It doesn’t list every file that’s changed, but each directory (folder) that’s had anything changed inside it.
  27. ^ de Guise, P. (2009). Enterprise Systems Backup and Recovery: A Corporate Insurance Policy. CRC Press. pp. 285–287. ISBN 978-1-4200-7639-4.
  28. ^ Wu, Victor (4 March 2017). “EMC RecoverPoint for Virtual Machine Overview”. Victor Virtual. WuChiKin. Retrieved 22 June 2019. The splitter splits out the Write IOs to the VMDK/RDM of a VM and sends a copy to the production VMDK and also to the RecoverPoint for VMs cluster.
  29. ^ “Zerto or Veeam?”. RES-Q Services. March 2017. Retrieved 7 July 2019. Zerto doesn’t use snapshot technology like Veeam. Instead, Zerto deploys small virtual machines on its physical hosts. These Zerto VMs capture the data as it is written to the host and then send a copy of that data to the replication site…..However, Veeam has the advantage of being able to more efficiently capture and store data for long-term retention needs. There is also a significant pricing difference, with Veeam being cheaper than Zerto.
  30. ^ “Agent Related”. CloudEndure.com. 2019. What does the CloudEndure Agent do?. Retrieved 3 July 2019. The CloudEndure Agent performs an initial block-level read of the content of any volume attached to the server and replicates it to the Replication Server. The Agent then acts as an OS-level read filter to capture writes and synchronizes any block level modifications to the CloudEndure Replication Server, ensuring near-zero RPO.
  31. ^ Gardner, Steve (9 December 2004). “Disk to Disk Backup versus Tape – War or Truce?”. Engenio. Peaceful coexistence. Archived from the original on 7 February 2005. Retrieved 26 May 2019.
  32. ^ Jump up to:a b c “Digital Data Storage Outlook 2017” (PDF). Spectra. Spectra Logic. 2017. p. 7(Solid-State), 10(Magnetic Disk), 14(Tape), 17(Optical). Retrieved 11 July 2018.
  33. ^ Jump up to:a b c Tom Coughlin (29 June 2014). “Keeping Data for a Long Time”. Forbes. para. Magnetic Tapes(popular formats, storage life), para. Hard Disk Drives(active archive), para. First consider flash memory in archiving(… may not have good media archive life). Retrieved 19 April 2018.
  34. ^ Jump up to:a b c d Jacobi, John L. (29 February 2016). “Hard-core data preservation: The best media and methods for archiving your data”. PC World. sec. External Hard Drives(on the shelf, magnetic properties, mechanical stresses, vulnerable to shocks), Tape, Online storage. Retrieved 19 April 2018.
  35. ^ “Ramp Load/Unload Technology in Hard Disk Drives” (PDF). HGST. Western Digital. November 2007. p. 3(sec. Enhanced Shock Tolerance). Retrieved 29 June 2018.
  36. ^ “Toshiba Portable Hard Drive (Canvio® 3.0)”. Toshiba Data Dynamics Singapore. Toshiba Data Dynamics Pte Ltd. 2018. sec. Overview(Internal shock sensor and ramp loading technology). Retrieved 16 June 2018.
  37. ^ Jump up to:a b “Iomega Drop Guard ™ Technology” (PDF). Hard Drive Storage Solutions. Iomega Corp. 20 September 2010. pp. 2(What is Drop Shock Technology?, What is Drop Guard Technology? (… features special internal cushioning …. 40% above the industry average)), 3(*NOTE). Retrieved 12 July 2018.
  38. ^ Jump up to:a b John Burek (15 May 2018). “The Best Rugged Hard Drives and SSDs”. PC Magazine. Ziff Davis. What Exactly Makes a Drive Rugged?(When a drive is encased … you’re mostly at the mercy of the drive vendor to tell you the rated maximum drop distance for the drive). Retrieved 4 August 2018.
  39. ^ Justin Krajeski; Kimber Streams (20 March 2017). “The Best Portable Hard Drive”. The New York Times. Archived from the original on 31 March 2017. Retrieved 4 August 2018.
  40. ^ “Best Long-Term Data Archive Solutions”. Iron Mountain. Iron Mountain Inc. 2018. sec. More Reliable(average mean time between failure … rates, best practice for migrating data). Retrieved 19 April 2018.
  41. ^ Kissell, Joe (2011). Take Control of Backing Up Your Mac. Ithaca NY: TidBITS Publishing Inc. p. 41(Deduplication). ISBN 978-1-61542-394-1. Retrieved 17 September 2019.
  42. ^ “Symantec Shows Backup Exec a Little Dedupe Love; Lays out Source Side Deduplication Roadmap – DCIG”. DCIG. 7 July 2009. Archived from the original on 4 March 2016. Retrieved 26 February 2016.
  43. ^ “Veritas NetBackup™ Deduplication Guide”. Veritas. Veritas Technologies LLC. 2016. Retrieved 26 July 2018.
  44. ^ S. Wan; Q. Cao; C. Xie (2014). “Optical storage: An emerging option in long-term digital preservation”. Frontiers of Optoelectronics. 7 (4): 486–492. doi:10.1007/s12200-014-0442-2. S2CID 60816607.
  45. ^ Q. Zhang; Z. Xia; Y.-B. Cheng; M. Gu (2018). “High-capacity optical long data memory based on enhanced Young’s modulus in nanoplasmonic hybrid glass composites”. Nature Communications. 9 (1): 1183. Bibcode:2018NatCo…9.1183Z. doi:10.1038/s41467-018-03589-y. PMC 5864957. PMID 29568055.
  46. ^ Bärwaldt, Erik (2014). “Full Control » Linux Magazine”. Linux Magazine.
  47. ^ “5. Conditions That Affect CDs and DVDs • CLIR”. CLIR.
  48. ^ Gérard Poirier; Foued Berahou (3 March 2008). “Journal de 20 Heures”. Institut national de l’audiovisuel. approximately minute 30 of the TV news broadcast. Retrieved 3 March 2008.
  49. ^ “Archival Gold CD-R “300 Year Disc” Binder of 10 Discs with Scratch Armor Surface”. Delkin Devices. Delkin Devices Inc. Archived from the original on 27 September 2013.
  50. ^ “Optical Disc Archive Generation 2” (PDF). Optical Disc Archive. Sony. April 2016. p. 12(World’s First 8-Channel Optical Drive Unit). Retrieved 15 August 2019.
  51. ^ R. Micheloni; P. Olivo (2017). “Solid-State Drives (SSDs)”. Proceedings of the IEEE. 105 (9): 1586–88. doi:10.1109/JPROC.2017.2727228.
  52. ^ “Remote Backup”. EMC Glossary. Dell, Inc. Retrieved 8 May 2018. Effective remote backup requires that production data be regularly backed up to a location far enough away from the primary location so that both locations would not be affected by the same disruptive event.
  53. ^ Stackpole, B.; Hanrion, P. (2007). Software Deployment, Updating, and Patching. CRC Press. pp. 164–165. ISBN 978-1-4200-1329-0. Retrieved 8 May 2018.
  54. ^ Gnanasundaram, S.; Shrivastava, A., eds. (2012). Information Storage and Management: Storing, Managing, and Protecting Digital Information in Classic, Virtualized, and Cloud Environments. John Wiley and Sons. p. 255. ISBN 978-1-118-23696-3. Retrieved 8 May 2018.
  55. ^ Lee (25 January 2017). “What to backup – a critical look at your data”. Irontree Blog. Irontree Internet Services CC. Retrieved 8 May 2018.
  56. ^ Preston, W.C. (2007). Backup & Recovery: Inexpensive Backup Solutions for Open Systems. O’Reilly Media, Inc. pp. 111–114. ISBN 978-0-596-55504-7. Retrieved 8 May 2018.
  57. ^ Preston, W.C. (1999). Unix Backup & Recovery. O’Reilly Media, Inc. pp. 73–91. ISBN 978-1-56592-642-4. Retrieved 8 May 2018.
  58. ^ “NILFS Home”. NILFS Continuous Snapshotting System. NILFS Community. 2019. Retrieved 22 August 2019.
  59. ^ Jump up to:a b Cougias, D.J.; Heiberger, E.L.; Koop, K. (2003). “Chapter 11: Open file backup for databases”. The Backup Book: Disaster Recovery from Desktop to Data Center. Network Frontiers. pp. 356–360. ISBN 0-9729039-0-9.
  60. ^ Liotine, M. (2003). Mission-critical Network Planning. Artech House. p. 244. ISBN 978-1-58053-559-5. Retrieved 8 May 2018.
  61. ^ de Guise, P. (2009). Enterprise Systems Backup and Recovery: A Corporate Insurance Policy. CRC Press. pp. 50–54. ISBN 978-1-4200-7639-4.
  62. ^ “Open File Backup Software for Windows”. Handy Backup. Novosoft LLC. 8 November 2018. Retrieved 29 November 2018.
  63. ^ Reitshamer, Stefan (5 July 2017). “Troubleshooting backing up open/locked files on Windows”. Arq Blog. Haystack Software. Stefan Reitshamer is the principal developer of Arq. Retrieved 29 November 2018.
  64. ^ Boss, Nina (10 December 1997). “Oracle Tips Session #3: Oracle Backups”. www.wisc.edu. University of Wisconsin. Archived from the original on 2 March 2007. Retrieved 1 December 2018.
  65. ^ “What is ARCHIVE-LOG and NO-ARCHIVE-LOG mode in Oracle and the advantages & disadvantages of these modes?”. Arcserve Backup. Arcserve. 27 September 2018. Retrieved 29 November 2018.
  66. ^ Grešovnik, Igor (April 2016). “Preparation of Bootable Media and Images”. Archived from the original on 25 April 2016. Retrieved 21 April 2016.
  67. ^ Tridgell, Andrew; Mackerras, Paul; Davison, Wayne. “rsync(1) – Linux man page”. linux.die.net.
  68. ^ “Archive maintenance”. Code42 Support. 2023.
  69. ^ Pond, James (2 June 2012). “12. Should I delete old backups? If so, How?”. Time Machine. baligu.com. Green box, Gray box. Retrieved 21 June 2019.
  70. ^ Kissell, Joe (12 March 2019). “The Best Online Cloud Backup Service”. wirecutter. The New York Times. Next, there’s file retention. Retrieved 21 June 2019.
  71. ^ Jump up to:a b c D. Cherry (2015). Securing SQL Server: Protecting Your Database from Attackers. Syngress. pp. 306–308. ISBN 978-0-12-801375-5. Retrieved 8 May 2018.
  72. ^ Backups tapes a backdoor for identity thieves Archived 5 April 2016 at the Wayback Machine (28 April 2004). Retrieved 10 March 2007
  73. ^ Jump up to:a b c Preston, W.C. (2007). Backup & Recovery: Inexpensive Backup Solutions for Open Systems. O’Reilly Media, Inc. pp. 219–220. ISBN 978-0-596-55504-7. Retrieved 8 May 2018.
  74. ^ “Recovery Point Objective (Definition)”. ARL Risky Thinking. Albion Research Ltd. 2007. Retrieved 4 August 2019.
  75. ^ “Recovery Time Objective (Definition)”. ARL Risky Thinking. Albion Research Ltd. 2007. Retrieved 4 August 2019.
  76. ^ Jump up to:a b Little, D.B. (2003). “Chapter 2: Business Requirements of Backup Systems”. Implementing Backup and Recovery: The Readiness Guide for the Enterprise. John Wiley and Sons. pp. 17–30. ISBN 978-0-471-48081-5. Retrieved 8 May 2018.
  77. ^ “How do the “verify” and “write checksums to media” processes work and why are they necessary?”. Veritas Support. Veritas.com. 15 October 2015. Write checksums to media. Retrieved 16 September 2019.
  78. ^ HIPAA Advisory Archived 11 April 2007 at the Wayback Machine. Retrieved 10 March 2007
  79.  Ahmadi-Javid, A.; Seyedi, P.; Syam, S. (2017). “A Survey of Healthcare Facility Location”. Computers & Operations Research. 79: 223–263. doi:10.1016/j.cor.2016.05.018.
  80. ^ AUSTRALIAN MEDICAL WORKFORCE BENCHMARKS (PDF). Australian Medical Workforce Advisory Committee (Report). Australian Institute of Health and Welfare. January 1996. p. 25. Archived from the original on August 6, 2010.
  81. ^ “Definition of Terms” (PDF). World Health Organization. Manila. 2010. Archived from the original on December 9, 2010.
  82. ^ Jump up to:a b “International Standard Industrial Classification of All Economic Activities Rev.3.1”. United Nations Statistics Division.
  83. Chien, Hung-Yu (2021-08-19). “Dynamic Public Key Certificates with Forward Secrecy”. Electronics. 10 (16): 2009. doi:10.3390/electronics10162009. ISSN 2079-9292.
  84. ^ “What is a certificate authority (CA)?”.
  85. ^ Villanueva, John Carl. “How do Digital Certificates Work – An Overview”. www.jscape.com. Retrieved 2021-09-05.
  86. ^ “Mozilla Included CA Certificate List — Mozilla”. Mozilla.org. Archived from the original on 2013-08-04. Retrieved 2014-06-11.
  87. ^ “EMV CA”. EMV Certificate Authority Worldwide. 2 October 2010. Retrieved February 17, 2019.
  88. ^ Zakir Durumeric; James Kasten; Michael Bailey; J. Alex Halderman (12 September 2013). “Analysis of the HTTPS Certificate Ecosystem” (PDF). The Internet Measurement Conference. SIGCOMM. Archived (PDF) from the original on 22 December 2013. Retrieved 20 December 2013.
  89. ^ “What is an SSL Certificate?”. Archived from the original on 2015-11-03. Retrieved 2022-03-19.
  90. ^ “webtrust”. webtrust. Archived from the original on 2013-08-18. Retrieved 2013-03-02.
  91. ^ Kirk Hall (April 2013). “Standards and Industry Regulations Applicable to Certification Authorities” (PDF). Trend Micro. Archived (PDF) from the original on 2016-03-04. Retrieved 2014-06-11.
  92. ^ “CA:IncludedCAs – MozillaWiki”. wiki.mozilla.org. Archived from the original on 2017-03-25. Retrieved 2017-03-18.
  93. ^ “List of available trusted root certificates in macOS High Sierra”. Apple Support. Retrieved 2020-08-24.
  94. ^ “Microsoft Included CA Certificate List”. ccadb-public.secure.force.com. Retrieved 2020-08-24.
  95. ^ “Security with HTTPS and SSL”. developer.android.com. Archived from the original on 2017-07-08. Retrieved 2017-06-09.
  96. ^ “Let’s Encrypt: Delivering SSL/TLS Everywhere” (Press release). Let’s Encrypt. Archived from the original on 2014-11-18. Retrieved 2014-11-20.
  97. ^ “About”. Let’s Encrypt. Archived from the original on 2015-06-10. Retrieved 2015-06-07.
  98. ^ “Counting SSL certificates – Netcraft”. news.netcraft.com. 13 May 2015. Archived from the original on 2015-05-16.
  99. ^ “DigiCert – World’s Largest High-Assurance Certificate Authority | Netcraft”. trends.netcraft.com.
  100. ^ “Usage statistics of SSL certificate authorities for websites, August 2024 – W3Techs”. w3techs.com.
  101. ^ “Baseline Requirements for the Issuance and Management of Publicly-Trusted Certificates, v.1.2.3” (PDF). Archived (PDF) from the original on 2015-03-23. Retrieved 2015-03-20.
  102. ^ “CA/Forbidden or Problematic Practices – MozillaWiki”. wiki.mozilla.org. Archived from the original on 2017-07-21. Retrieved 2017-07-06.
  103. ^ “SSL FAQ – Frequently Asked Questions – Rapid SSL”. www.rapidssl.com. Archived from the original on 2015-02-06.
  104. ^ Zusman, Mike (2009). Criminal charges are not pursued: Hacking PKI (PDF). DEF CON 17. Las Vegas. Archived (PDF) from the original on 2013-04-15.
  105. ^ “A Finnish man created this simple email account – and received Microsoft’s security certificate”. tivi.fi. Archived from the original on 2015-08-08.
  106. ^ “Responsibilities of Certificate Authority”. Archived from the original on 2015-02-12. Retrieved 2015-02-12.
  107. ^ “Network World”. 17 January 2000.
  108. ^ Applied Cryptography and Network Security: Second International Conference, ACNS 2004, Yellow Mountain, China, June 8-11, 2004. Proceedings. Springer. June 2004. ISBN 9783540222170.
  109. ^ The Shortcut Guide to Managing Certificate Lifecycles. Realtimepublishers.com. 2006. ISBN 9781931491594.
  110. ^ “Electronic Signatures and Records” (PDF). Archived (PDF) from the original on 2016-03-04. Retrieved 2014-08-28.
  111. ^ “Certificate transparency”. Archived from the original on 2013-11-01. Retrieved 2013-11-03.
  112. ^ B. Laurie; A. Langley; E. Kasper (June 2013). Certificate Transparency. Internet Engineering Task Force. doi:10.17487/RFC6962. ISSN 2070-1721. RFC 6962. Experimental. |- |6963 |A Uniform Resource Name (URN) Namespace for Examples |Best Current Practice 183 |P. Saint-Andre (May 2013). A Uniform Resource Name (URN) Namespace for Examples. Internet Engineering Task Force. doi:10.17487/RFC6963. ISSN 2070-1721. BCP 183. RFC 6963. |Updates RFC 1930. |- |6979 |Deterministic Usage of the Digital Signature Algorithm (DSA) and Elliptic Curve Digital Signature Algorithm (ECDSA) |Informational |T. Pornin (August 2013). Deterministic Usage of the Digital Signature Algorithm (DSA) and Elliptic Curve Digital Signature Algorithm (ECDSA). Independent Submission. doi:10.17487/RFC6979. ISSN 2070-1721. RFC 6979. | |- |6980 |Security Implications of IPv6 Fragmentation with IPv6 Neighbor Discovery |Proposed Standard |F. Gont (August 2013). Security Implications of IPv6 Fragmentation with IPv6 Neighbor Discovery. Internet Engineering Task Force. doi:10.17487/RFC6980. ISSN 2070-1721. RFC 6980. |Updates RFC 3971 and 4861. |- |6996 |Autonomous System (AS) Reservation for Private Use |Best Current Practice 6 |J. Mitchell (July 2013). Autonomous System (AS) Reservation for Private Use. Internet Engineering Task Force. doi:10.17487/RFC6996. ISSN 2070-1721. BCP 6. RFC 6996. |Updates RFC 1930. |} ← prev | next →
  113. ^ Smith, Dickinson & Seamons 2020, p. 1.
  114. ^ Jump up to:a b Sheffer, Saint-Andre & Fossati 2022, 7.5. Certificate Revocation.
  115. ^ Chung et al. 2018, p. 3.
  116. ^ Smith, Dickinson & Seamons 2020, p. 10.
  117. ^ Larisch et al. 2017, p. 542.
  118. ^ Smith, Dickinson & Seamons 2020, p. 1-2.
  119. ^ “Multivendor power council formed to address digital certificate issues”. Network World. February 14, 2013. Archived from the original on July 28, 2013.
  120. ^ “Major Certificate Authorities Unite In The Name Of SSL Security”. Dark Reading. February 14, 2013. Archived from the original on April 10, 2013.
  121. ^ “CA/Browser Forum Founder”. Archived from the original on 2014-08-23. Retrieved 2014-08-23.
  122. ^ “CA/Browser Forum”. Archived from the original on 2013-05-12. Retrieved 2013-04-23.
  123. ^ Wilson, Wilson. “CA/Browser Forum History” (PDF). DigiCert. Archived (PDF) from the original on 2013-05-12. Retrieved 2013-04-23.
  124. ^ “Baseline Requirements”. CAB Forum. 4 September 2013. Archived from the original on 7 January 2014. Retrieved 14 April 2017.
  125. ^ “Mozilla Root Store Policy”. Mozilla. Archived from the original on 15 April 2017. Retrieved 14 April 2017.
  126. ^ “Apple Root Certificate Program”. Apple. Archived from the original on 20 March 2017. Retrieved 14 April 2017.
  127. ^ “CA-2001-04”. Cert.org. 31 December 2001. Archived from the original on 2013-11-02. Retrieved 2014-06-11.
  128. ^ Microsoft, Inc. (2007-02-21). “Microsoft Security Bulletin MS01-017: Erroneous VeriSign-Issued Digital Certificates Pose Spoofing Hazard”. Archived from the original on 2011-10-26. Retrieved 2011-11-09.
  129. ^ Seltzer, Larry. “SSL Certificate Vendor Sells Mozilla.com CSSL Certificate to Some Guy”. eWeek. Retrieved 5 December 2021.
  130. ^ Bright, Peter (28 March 2011). “Independent Iranian hacker claims responsibility for Comodo hack”. Ars Technica. Archived from the original on 29 August 2011. Retrieved 2011-09-01.
  131. ^ Bright, Peter (2011-08-30). “Another fraudulent certificate raises the same old questions about certificate authorities”. Ars Technica. Archived from the original on 2011-09-12. Retrieved 2011-09-01.
  132. ^ Leyden, John (2011-09-06). “Inside ‘Operation Black Tulip’: DigiNotar hack analysed”. The Register. Archived from the original on 2017-07-03.
  133. ^ “Trustwave issued a man-in-the-middle certificate”. The H Security. 2012-02-07. Archived from the original on 2012-03-13. Retrieved 2012-03-14.
  134. ^ “Flame malware collision attack explained | MSRC Blog | Microsoft Security Response Center”. msrc.microsoft.com. Retrieved 2023-10-13.
  135. ^ Goodin, Dan (2012-06-07). “Crypto breakthrough shows Flame was designed by world-class scientists”. Ars Technica. Retrieved 2023-10-13.
  136. ^ Fisher, Dennis (2015-03-23). “CA Linked to Chinese Registrar Issued Unauthorized Google Certificates”. ThreatPost. Retrieved 2023-09-27.
  137. ^ Langley, Adam (2015-03-23). “Maintaining digital certificate security”. Google Security Blog. Retrieved 2023-09-27.
  138. ^ Lowenthal, Tom (2015-03-31). “China’s CNNIC issues false certificates in serious breach of crypto trust”. Committee to Protect Journalists. Retrieved 2023-10-13.
  139. ^ Osborne, Charlie. “Symantec sacks staff for issuing unauthorized Google certificates – ZDNet”. ZDNet. Archived from the original on 2016-10-02.
  140. ^ “Unauthorized Google Digital Certificates Discovered”. linkedin.com. 12 August 2014.
  141. ^ “In the Wake of Unauthorized Certificate Issuance by the Indian CA NIC, can Government CAs Still be Considered “Trusted Third Parties”?”. casecurity.org. 24 July 2014. Archived from the original on 3 October 2016.
  142. McNeil JJ, Piccenna L, Ronaldson K, et al. (2010). “The Value of Patient-Centred Registries in Phase IV Drug Surveillance”. Pharm Med. 24 (5): 281–288. doi:10.1007/bf03256826. S2CID 19091146. Archived from the original on 2012-07-07. Retrieved 2011-06-17.
  143. ^ “Post-marketing Pharmacosurveillance in Canada”. Health Canada. 2005. Archived from the original on 2010-09-28. Retrieved 2010-07-27.
  144. ^ IVDR – 2017/746
  145. ^ Zippel, Claus; Bohnet-Joschko, Sabine (2017). “Post market surveillance in the german medical device sector – current state and future perspectives”. Health Policy (Amsterdam, Netherlands). 121 (8): 880–886. doi:10.1016/j.healthpol.2017.06.005. ISSN 1872-6054. PMID 28697849.
  146. ^ “Post-Market Surveillance and Vigilance: MDR vs IVDR”. citemedical.com. 10 May 2022.
  147. ^ MDCG Guideline 2023-3
  148. ^ “Post-marketing Surveillance”. U.S. FDA/CDER. 2004.
  149. ^ “Post-Approval Studies”. U.S. FDA/CDRH. 2014.
  150. ^ “522 Postmarket Surveillance Studies”. U.S. FDA/CDRH. 2014.
  151. ^ FDA (3 November 2018). “Postmarketing Requirements and Commitments: Introduction”. Food and Drug Administration.
  152.  Fadahunsi, Kayode Philip; Akinlua, James Tosin; O’Connor, Siobhan; Wark, Petra A; Gallagher, Joseph; Carroll, Christopher; Majeed, Azeem; O’Donoghue, John (March 2019). “Protocol for a systematic review and qualitative synthesis of information quality frameworks in eHealth”. BMJ Open. 9 (3): e024722. doi:10.1136/bmjopen-2018-024722. ISSN 2044-6055. PMC 6429947. PMID 30842114.
  153. ^ “World Alliance for Patient Safety”. Organization Web Site. World Health Organization. Archived from the original on 2008-10-03. Retrieved 2008-09-27.
  154. ^ Patrick A. Palmieri; et al. (2008). “The anatomy and physiology of error in adverse health care events”. The anatomy and physiology of error in averse healthcare events. Vol. 7. pp. 33–68. doi:10.1016/S1474-8231(08)07003-1. ISBN 978-1-84663-954-8. {{cite book}}: |journal= ignored (help)
  155. ^ Tan, Yong Yu; Woulfe, Fionn; Chirambo, Griphin Baxter; Henn, Patrick; Cilliers, Liezel; Fadahunsi, Kayode Philip; Taylor-Robinson, Simon D.; O’Donoghue, John (2022-10-01). “Framework to assess the quality of mHealth apps: a mixed-method international case study protocol”. BMJ Open. 12 (10): e062909. doi:10.1136/bmjopen-2022-062909. ISSN 2044-6055. PMC 9621190. PMID 36307160.
  156. ^ National Institute of Health, History of Medicine: Greek Medicine|[https://web.archive.org/web/20180307132605/https://www.nlm.nih.gov/hmd/greek/greek_oath.html Archived 2018-03-07 at the Wayback Machine
  157. ^ The Anesthesia Patient Safety Foundation, A Brief History Archived 2006-01-13 at the Wayback Machine
  158. ^ Janice Tomlin (producer): The Deep Sleep: 6,000 will die or suffer brain damage, WLS-TV Chicago, 20/20. April 22, 1982
  159. ^ Anesthesia Patient Safety Foundation: The establishment of the APSF Archived 2006-04-16 at the Wayback Machine by Ellison C. Pierce, Jr., M.D.
  160. ^ Howanitz, Peter J. (2005-10-01). “Errors in Laboratory Medicine: Practical Lessons to Improve Patient Safety”. Archives of Pathology & Laboratory Medicine. 129 (10): 1252–1261. doi:10.5858/2005-129-1252-EILMPL. ISSN 1543-2165. PMID 16196513.
  161. ^ Anesthesia Patient Safety Foundation: Comments From the Anesthesia Patient Safety Foundation Archived 2012-03-27 at the Wayback Machine
  162. ^ David M Gaba (2000). “Anesthesiology as a model for patient safety in health care”. Medical Care. 320 (7237): 785–788. doi:10.1136/bmj.320.7237.785. PMC 1117775. PMID 10720368.
  163. ^ Thomas, Eric J.; et al. (2000). “Incidence and Types of Adverse Events and Negligent Care in Utah and Colorado (Abstract)”. Medical Care. 38 (3): 261–271. doi:10.1097/00005650-200003000-00003. PMID 10718351. Retrieved 2006-06-23.
  164. ^ “Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I”. N. Engl. J. Med. 324 (6): 370–6. 1991. doi:10.1056/NEJM199102073240604. PMID 1987460. S2CID 52850777. {{cite journal}}: Unknown parameter |authors= ignored (help)
  165. ^ Jump up to:a b Institute of Medicine (US) Committee on Quality of Health Care in America; Kohn, L. T.; Corrigan, J. M.; Donaldson, M. S. (2000). Kohn, Linda T.; Corrigan, Janet M.; Donaldson, Molla S. (eds.). To Err is Human—Building a Safer Health System. Washington, D. C.: National Academies Press. p. 312. doi:10.17226/9728. ISBN 978-0-309-06837-6. PMID 25077248.
  166. ^ Charatan, Fred (2000). “Clinton acts to reduce medical mistakes”. BMJ. 320 (7235): 597. doi:10.1136/bmj.320.7235.597. PMC 1117638. PMID 10698861.
  167. ^ Harold C. Sox, Jr; Steven Woloshin (2000). “How Many Deaths Are Due to Medical Error? Getting the Number Right”. Effective Clinical Practice. Archived from the original on 2006-02-06. Retrieved 2006-06-22.
  168. ^ Commonwealth Fund International Survey: Taking the Pulse of Health Care Systems: Experiences of Patients with Health Problems in Six Countries Archived 2006-06-21 at the Wayback Machine (2005)
  169. ^ KABLE, A. K.; Gibberd, R. W.; Spigelman, A. D. (2002-08-01). “Adverse events in surgical patients in Australia”. International Journal for Quality in Health Care. 14 (4): 269–276. doi:10.1093/intqhc/14.4.269. ISSN 1353-4505. PMID 12201185.
  170. ^ Australian Broadcasting Corporation, The World Today: Concerns over medication errors in Australian hospitals Archived 2005-05-10 at the Wayback Machine
  171. ^ Department of Health Expert Group (2000). “An organisation with a memory”. Department of Health, United Kingdom. Archived from the original on 2006-06-29. Retrieved 2006-07-01.
  172. ^ G. Ross Baker; Peter G. Norton; et al. (2004). “The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada”. Canadian Medical Association Journal. 170 (11): 1678–1685. doi:10.1503/cmaj.1040498. PMC 408508. PMID 15159366.
  173. ^ “Adverse Events in New Zealand Public Hospitals: Principal Findings from a National Survey”. New Zealand Ministry of Health. December 2001. Archived from the original on 2006-08-13. Retrieved 2006-07-15.
  174. ^ “[Incidence of adverse events in hospitals. A retrospective study of medical records]”. Ugeskrift for Læger (in Danish). 163 (39): 5370–8. September 2001. PMID 11590953. {{cite journal}}: Unknown parameter |authors= ignored (help)
  175. ^ World Alliance for Patient Safety: “Patient safety_a global priority” (PDF). Archived from the original (PDF) on 2005-11-05. Retrieved 2006-07-15. (56.6 KiB) Editorial, December 2004 (retrieved on July 15, 2006)
  176. ^ Jump up to:a b World Health Organization: 10 facts on patient safety Accessed 2008-05-19
  177. ^ Edmondson, Amy C. (2019). The fearless organization: creating psychological safety in the workplace for learning, innovation, and growth. Hoboken, New Jersey: Wiley. ISBN 9781119477242.
  178. ^ Newman, Alexander; Donohue, Ross; Eva, Nathan (1 September 2017). “Psychological safety: A systematic review of the literature”. Human Resource Management Review. 27 (3): 521–535. doi:10.1016/j.hrmr.2017.01.001.
  179. ^ Jump up to:a b Hannawa, Annegret; Wu, Albert; Juhasz, Robert (2017-03-06). New Horizons in Patient Safety: Understanding Communication: Case Studies for Physicians. De Gruyter. doi:10.1515/9783110455014. ISBN 978-3-11-045501-4.
  180. ^ Hannawa, Annegret; Wendt, Anne; Day, Lisa (2017-12-18). New Horizons in Patient Safety: Safe Communication. De Gruyter. doi:10.1515/9783110454857. ISBN 978-3-11-045485-7.
  181. ^ “SACCIA Safe Communication”. prof. annegret hannawa. Retrieved 2021-04-21.
  182. ^ Jump up to:a b c Hannawa, Annegret F (June 2018). “”SACCIA Safe Communication”: Five core competencies for safe and high-quality care”. Journal of Patient Safety and Risk Management. 23 (3): 99–107. doi:10.1177/2516043518774445. ISSN 2516-0435. S2CID 169364817.
  183. ^ “Medical Error Disclosure Competence (MEDC) — Prof. Dr. Annegret Hannawa”. prof. annegret hannawa. Retrieved 2021-04-21.
  184. ^ Jump up to:a b c d e f g h i The Safety Competencies – Enhancing Patient Safety Across the Health Professions (PDF) (first ed.). Canadian Patient Safety Institute. August 2009. ISBN 978-1-926541-15-0. Archived from the original (PDF) on 2013-06-14. Retrieved 2014-11-04. {{cite book}}: Unknown parameter |authors= ignored (help)
  185. ^ Jump up to:a b Hannawa, Annegret F. (October 2019). “When facing our fallibility constitutes “safe practice”: Further evidence for the Medical Error Disclosure Competence (MEDC) guidelines”. Patient Education and Counseling. 102 (10): 1840–1846. doi:10.1016/j.pec.2019.04.024. PMID 31064681. S2CID 147706347.
  186. ^ David Marx. “Patient Safety and the “Just Culture:” A Primer For Health Care Executives” (PDF). University of California Los Angeles. Archived from the original (PDF) on 2016-03-03. Retrieved 30 October 2014.
  187. ^ “Canadian Disclosure Guidelines BEING OPEN WITH PATIENTS AND FAMILIES” (PDF). Patient Safety Institute. p. 16. Archived from the original (PDF) on 2015-01-22. Retrieved 30 October 2014.
  188. ^ Wolf, Zane Robinson; Hughes, Ronda G. “Chapter 35”. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Agency for Healthcare Research and Quality.
  189. ^ Kunadharaju, Kumar; Smith, Todd; DeJoy, David (May 2011). “Line-of-duty deaths among U.S. firefighters: An analysis of fatality investigations”. Accident Analysis & Prevention. 43 (3): 1171–1180. doi:10.1016/j.aap.2010.12.030. PMID 21376916.
  190. ^ Hannawa, Annegret F.; Roter, Debra L. (November 2013). “TRACEing the roots: A diagnostic “Tool for Retrospective Analysis of Critical Events””. Patient Education and Counseling. 93 (2): 230–238. doi:10.1016/j.pec.2013.06.019. PMID 23891421.
  191. ^ “Archived copy” (PDF). Archived (PDF) from the original on 2014-08-23. Retrieved 2014-11-04.
  192. ^ Jump up to:a b “Royal College of Physicians and Surgeons of Canada / Collège royal des médecins et chirurgiens du Canada” (PDF). Archived (PDF) from the original on 2014-11-04. Retrieved 2014-11-04.
  193. ^ O’Connor, Elaine; Coates, Hilary M.; Yardley, Iain E.; Wu, Albert W. (October 2010). “Disclosure of patient safety incidents: A comprehensive review” (PDF). International Journal for Quality in Health Care. 22 (5): 371–379. doi:10.1093/intqhc/mzq042. PMID 20709703. Archived from the original (PDF) on 2014-11-04. Retrieved 2014-11-04.
  194. ^ Hannawa, A. F. (2017-03-13). “What constitutes “competent error disclosure”? Insights from a national focus group study in Switzerland”. Swiss Medical Weekly. 147 (1112): w14427. doi:10.4414/smw.2017.14427. ISSN 1424-7860. PMID 28466465.
  195. ^ Hannawa, Annegret F.; Frankel, Richard M. (2018-07-20). “”It Matters What I Think, Not What You Say”: Scientific Evidence for a Medical Error Disclosure Competence (MEDC) Model”. Journal of Patient Safety. 17 (8): e1130 – e1137. doi:10.1097/PTS.0000000000000524. ISSN 1549-8417. PMID 30036286. S2CID 51711124.
  196. ^ Paul A, Gluck, MD: Medical Errors: Incidence, Theories, Myths and Solutions (Presentation at the Seminole County Patient Safety Summit Archived 2008-12-11 at the Wayback Machine, April 22, 2006)
  197. ^ Jump up to:a b c “Epidemiology of medical error”. BMJ. 320 (7237): 774–7. March 2000. doi:10.1136/bmj.320.7237.774. PMC 1117772. PMID 10720365. {{cite journal}}: Unknown parameter |authors= ignored (help)
  198. ^ “Do house officers learn from their mistakes?”. JAMA. 265 (16): 2089–94. April 1991. doi:10.1001/jama.265.16.2089. PMID 2013929. {{cite journal}}: Unknown parameter |authors= ignored (help)
  199. ^ Jump up to:a b c Neale, G; Woloshynowych, M; Vincent, C (July 2001). “Exploring the causes of adverse events in NHS hospital practice”. Journal of the Royal Society of Medicine. 94 (7): 322–30. doi:10.1177/014107680109400702. PMC 1281594. PMID 11418700.
  200. ^ “Doctors’ working hours: can the medical profession afford to let the courts decide what is reasonable?”. Med J Aust. 168 (12): 616–8. June 1998. doi:10.5694/j.1326-5377.1998.tb141450.x. PMID 9673625. S2CID 34759813. Archived from the original on 2006-08-19. Retrieved 2006-07-01. {{cite journal}}: Unknown parameter |authors= ignored (help)
  201. ^ “Effect of reducing interns’ work hours on serious medical errors in intensive care units”. N. Engl. J. Med. 351 (18): 1838–48. 2004. doi:10.1056/NEJMoa041406. PMID 15509817. S2CID 20197603. {{cite journal}}: Unknown parameter |authors= ignored (help)
  202. ^ “Impact of extended-duration shifts on medical errors, adverse events, and attentional failures”. PLOS Med. 3 (12): e487. December 2006. doi:10.1371/journal.pmed.0030487. PMC 1705824. PMID 17194188. {{cite journal}}: Unknown parameter |authors= ignored (help)
  203. ^ “Rates of medication errors among depressed and burnt out residents: prospective cohort study”. BMJ. 336 (7642): 488–91. March 2008. doi:10.1136/bmj.39469.763218.BE. PMC 2258399. PMID 18258931. Archived from the original on 2008-03-28. {{cite journal}}: Unknown parameter |authors= ignored (help)
  204. ^ Michael L. Millenson (2003). “The Silence”. Health Affairs. 22 (2): 103–112. doi:10.1377/hlthaff.22.2.103. PMID 12674412. S2CID 40037135.
  205. ^ Elizabeth A. Henneman, RN, CCNS (1 October 2007). “Unreported Errors in the Intensive Care Unit, A Case Study of the Way We Work”. Critical Care Nurse. 27 (5): 27–34. doi:10.4037/ccn2007.27.5.27. PMID 17901458. Archived from the original on 2008-10-13. Retrieved 2008-03-23.
  206. ^ Wagar, Elizabeth A.; Tamashiro, Lorraine; Yasin, Bushra; Hilborne, Lee; Bruckner, David A. (2006-11-01). “Patient Safety in the Clinical Laboratory: A Longitudinal Analysis of Specimen Identification Errors”. Archives of Pathology & Laboratory Medicine. 130 (11): 1662–1668. doi:10.5858/2006-130-1662-PSITCL. ISSN 1543-2165. PMID 17076528.
  207. ^ Otto, Catherine N. (April 2011). “Patient Safety and the Medical Laboratory An Introduction”. American Society for Clinical Laboratory Science. 24 (2): 105–107. doi:10.29074/ascls.24.2.105. ISSN 0894-959X. PMID 21657143.
  208. ^ Hannawa, Annegret; Wendt, Anne; Day, Lisa J. (2017-12-04). New Horizons in Patient Safety: Safe Communication: Evidence-based core Competencies with Case Studies from Nursing Practice. De Gruyter. doi:10.1515/9783110454857. ISBN 978-3-11-045485-7.
  209. ^ “Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction”. JAMA. 288 (16): 1987–93. 2002. doi:10.1001/jama.288.16.1987. PMID 12387650. {{cite journal}}: Unknown parameter |authors= ignored (help)
  210. ^ Jump up to:a b Gardner, Amanda (6 March 2007). “Medication Errors During Surgeries Particularly Dangerous”. The Washington Post. Archived from the original on 2012-10-26. Retrieved 2007-03-13.
  211. ^ 8th Annual MEDMARX Report (2008-01-29). “Press Release”. U.S. Pharmacopeia. Archived from the original on 2008-02-08. Retrieved 2008-03-23.
  212. ^ Jump up to:a b McDonald, Clement J. (4 April 2006). “Computerization Can Create Safety Hazards: A Bar-Coding Near Miss”. Annals of Internal Medicine. 144 (7): 510–516. doi:10.7326/0003-4819-144-7-200604040-00010. PMID 16585665.
  213. ^ US Agency for Healthcare Research & Quality (2008-01-09). “Physicians Want To Learn from Medical Mistakes but Say Current Error-reporting Systems Are Inadequate”. Archived from the original on 2008-02-17. Retrieved 2008-03-23.
  214. ^ “Does the patient’s payer matter in hospital patient safety?: a study of urban hospitals”. Med Care. 45 (2): 131–8. February 2007. doi:10.1097/01.mlr.0000244636.54588.2b. PMID 17224775. S2CID 22206854. {{cite journal}}: Unknown parameter |authors= ignored (help)
  215. ^ “Incorporating Patient-Safe Design into the Guidelines”. The American Institute of Architects Academy Journal. 2005-10-19. Archived from the original on 2006-10-07. Retrieved 2007-01-28.
  216. ^ The Joint Commission’s Annual Report on Quality and Safety 2007: Improving America’s Hospitals Archived 2008-04-16 at the Wayback Machine (Accessed 2008-04-09)
  217. ^ Jump up to:a b René Amalberti; Yves Auroy; Don Berwick; Paul Barach (3 May 2005). “Five System Barriers to Achieving Ultrasafe Health Care”. Annals of Internal Medicine. 142 (9): 756–764. doi:10.7326/0003-4819-142-9-200505030-00012. PMID 15867408.
  218. ^ Institute of Medicine (1999). “To Err Is Human: Building a Safer Health System, page 4”. The National Academies Press. Archived from the original on 2006-09-13. Retrieved 2006-07-01.
  219. ^ Hall, Louise H.; Johnson, Judith; Watt, Ian; Tsipa, Anastasia; O’Connor, Daryl B. (2016-07-08). “Healthcare Staff Wellbeing, Burnout, and Patient Safety: A Systematic Review”. PLOS ONE. 11 (7): e0159015. Bibcode:2016PLoSO..1159015H. doi:10.1371/journal.pone.0159015. ISSN 1932-6203. PMC 4938539. PMID 27391946.
  220. ^ Garcia, Cíntia de Lima; Abreu, Luiz Carlos de; Ramos, José Lucas Souza; Castro, Caroline Feitosa Dibai de; Smiderle, Fabiana Rosa Neves; Santos, Jaçamar Aldenora dos; Bezerra, Italla Maria Pinheiro (September 2019). “Influence of Burnout on Patient Safety: Systematic Review and Meta-Analysis”. Medicina. 55 (9): 553. doi:10.3390/medicina55090553. ISSN 1648-9144. PMC 6780563. PMID 31480365.
  221. ^ Reith, Thomas P (2018). “Burnout in United States Healthcare Professionals: A Narrative Review”. Cureus. 10 (12): e3681. doi:10.7759/cureus.3681. ISSN 2168-8184. PMC 6367114. PMID 30761233.
  222. ^ Jump up to:a b Dall’Ora, Chiara; Ball, Jane; Reinius, Maria; Griffiths, Peter (2020-06-05). “Burnout in nursing: a theoretical review”. Human Resources for Health. 18 (1): 41. doi:10.1186/s12960-020-00469-9. ISSN 1478-4491. PMC 7273381. PMID 32503559.
  223. ^ Jump up to:a b Prapanjaroensin, Aoyjai; Patrician, Patricia A.; Vance, David E. (November 2017). “Conservation of resources theory in nurse burnout and patient safety”. Journal of Advanced Nursing. 73 (11): 2558–2565. doi:10.1111/jan.13348. PMID 28543427. S2CID 28686505.
  224. ^ Kakemam, Edris; Chegini, Zahra; Rouhi, Amin; Ahmadi, Forouzan; Majidi, Soheila (October 2021). “Burnout and its relationship to self-reported quality of patient care and adverse events during COVID-19: A cross-sectional online survey among nurses”. Journal of Nursing Management. 29 (7): 1974–1982. doi:10.1111/jonm.13359. ISSN 0966-0429. PMC 8237033. PMID 33966312.
  225. ^ Federal Aviation Administration (FAA): Accidents and Accident Rates, 1986 through 2005, U.S. Air Carriers Archived 2006-09-30 at the Wayback Machine
  226. ^ Robert Helmreich (2000). “On error management: lessons from aviation”. British Medical Journal. 320 (7237): 781–785. doi:10.1136/bmj.320.7237.781. PMC 1117774. PMID 10720367. Retrieved 2006-06-24.
  227. ^ J Bryan Sexton; Eric J Thomas; Robert L Helmreich (2000). “Error, stress, and teamwork in medicine and aviation”. British Medical Journal. 320 (7237): 745–749. doi:10.1136/bmj.320.7237.745. PMC 27316. PMID 10720356.
  228. ^ Jump up to:a b Wald, Matthew L. (October 1, 2007). “Fatal Airplane Crashes Drop 65%”. The New York Times. Archived from the original on 2011-07-09. Retrieved 2007-10-01.
  229. ^ “Federal patient safety initiatives panel summary”. J Am Med Inform Assoc. 9 (6 Suppl): S8–10. 2002. doi:10.1197/jamia.M1217. PMC 419408. PMID 12386172. {{cite journal}}: Unknown parameter |authors= ignored (help)
  230. ^ “United 173 – The Need for CRM”. www.goflightmedicine.com. 8 July 2014. Archived from the original on 2014-10-06. Retrieved 30 Sep 2014.
  231. ^ Mandak, Joe (September 18, 2005). “Database seeks to lower firefighter deaths”. USA Today. Archived from the original on 2008-02-22. Retrieved 2006-07-08.
  232. ^ AORN: SafetyNet Archived 2006-07-17 at the Wayback Machine
  233. ^ “AlmostME”. www.almostme.com. Archived from the original on 2018-08-27. Retrieved 2018-12-05.
  234. ^ “Improving patient safety in hospitals: Contributions of high-reliability theory and normal accident theory”. Health Serv Res. 41 (4 Pt 2): 1654–76. August 2006. doi:10.1111/j.1475-6773.2006.00570.x. PMC 1955347. PMID 16898984. {{cite journal}}: Unknown parameter |authors= ignored (help)
  235. ^ RAND Healthcare: Health Information Technology: Can HIT Lower Costs and Improve Quality? Archived 2015-06-30 at the Wayback Machine Retrieved on July 8, 2006
  236. ^ Ross Koppel; et al. (2005). “Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors”. JAMA. 293 (10): 1197–1203. doi:10.1001/jama.293.10.1197. PMID 15755942.
  237. ^ Institute of Medicine (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. The National Academies Press. doi:10.17226/10027. ISBN 978-0-309-07280-9. PMID 25057539. Archived from the original on 2006-06-15. Retrieved 2006-06-29.
  238. ^ American College of Physicians Observer: How EMR software can help prevent medical mistakes Archived 2008-08-30 at the Wayback Machine by Jerome H. Carter (September 2004)
  239. ^ Kensaku Kawamoto, fellow1, Caitlin A Houlihan, E Andrew Balas, David F Lobach (2005). “Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success”. British Medical Journal. 330 (7494): 765–768. doi:10.1136/bmj.38398.500764.8F. PMC 555881. PMID 15767266.
  240. ^ C J Morris; B S P Savelyich; A J Avery; J A Cantrill; A Sheikh (2005). “Patient safety features of clinical computer systems: questionnaire survey of GP views”. Quality and Safety in Health Care. 14 (3): 164–168. doi:10.1136/qshc.2004.011866. PMC 1744017. PMID 15933310.
  241. ^ “Verification Screen That Includes Prominent Patient Photograph Significantly Reduces Errors Caused by Orders Placed in Wrong Chart”. AHRQ Health Care Innovations Exchange. 2013-04-24. Archived from the original on 2017-01-31. Retrieved 2013-04-26.
  242. ^ EMERGENTag Archived 2009-05-05 at the Wayback Machine, portable offline emergency medical record
  243. ^ “DEPATISnet – Bibliographische Daten”. depatisnet.dpma.de.
  244. ^ Jump up to:a b c d The Institute of Medicine (2006). Preventing Medication Errors. doi:10.17226/11623. ISBN 978-0-309-10147-9. Archived from the original on 2006-09-01. Retrieved 2006-07-21. {{cite book}}: |journal= ignored (help)
  245. ^ David W. Bates; et al. (1998). “Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication Errors”. JAMA. 280 (15): 1311–1316. doi:10.1001/jama.280.15.1311. PMID 9794308.
  246. ^ “Hospital Quality & Safety Survey” (PDF). The Leapfrog Group. 2004. Archived from the original (PDF) on 2006-09-03. Retrieved 2006-07-08.
  247. ^ Kaufman, Marc (2005-07-21). “Medication Errors Harming Millions, Report Says. Extensive National Study Finds Widespread, Costly Mistakes in Giving and Taking Medicine”. The Washington Post. pp. A08. Archived from the original on 2008-09-04. Retrieved 2006-07-21.
  248. ^ Lohr, Steve (2005-03-09). “Doctors’ Journal Says Computing Is No Panacea”. The New York Times. Archived from the original on 2007-01-23. Retrieved 2006-07-15.
  249. ^ Patrick Palmieri; et al. (2007). “Technological iatrogenesis: New risks force heightened management awareness” (PDF). Journal of Healthcare Risk Management. 27 (4): 19–24. doi:10.1002/jhrm.5600270405. PMID 20200891. Archived from the original (PDF) on 2008-12-17. Retrieved 2008-07-02.
  250. ^ Weiner; Kfuri, T; Chan, K; Fowles, JB; et al. (2007). “e-Iatrogenesis: The most critical unintended consequence of CPOE and other HIT”. Journal of the American Medical Informatics Association. 14 (3): 387–388. doi:10.1197/jamia.M2338. PMC 2244888. PMID 17329719.
  251. ^ Santell, John P (2004). “Computer Related Errors: What Every Pharmacist Should Know” (PDF). United States Pharmacopia. Archived from the original (PDF) on 2008-11-20. Retrieved 2006-06-20.
  252. ^ “Acute pharyngitis algorithm”, guideline.gov
  253. ^ David L Sackett; William M C Rosenberg; J A Muir Gray; R Brian Haynes; W Scott Richardson (1996). “Editorials: Evidence based medicine: what it is and what it isn’t”. British Medical Journal. 312 (7023): 71–72. doi:10.1136/bmj.312.7023.71. PMC 2349778. PMID 8555924.
  254. ^ Agency for Healthcare Research and Quality: The National Guideline Clearinghouse Archived 2006-07-15 at the Wayback Machine
  255. ^ The National Institute for Health and Clinical Excellence (NICE) Providing national guidance on promoting good health Archived 2006-07-10 at the Wayback Machine
  256. ^ G. Ollenschlaeger, C. Marshall, S. Qureshi et al.: Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care 2004;13:455-460 Archived 2009-03-28 at the Wayback Machine
  257. ^ Sciacovelli, Laura; Plebani, Mario (June 2009). “The IFCC Working Group on laboratory errors and patient safety”. Clinica Chimica Acta. 404 (1): 79–85. doi:10.1016/j.cca.2009.03.025. PMID 19328194.
  258. ^ William Rosenberg; Anna Donald (1995). “Evidence based medicine: an approach to clinical problem-solving”. British Medical Journal. 310 (6987): 1122–1126. doi:10.1136/bmj.310.6987.1122. PMC 2549505. PMID 7742682.
  259. ^ Institute of Medicine: Guidelines for Clinical Practice: From Development to Use[permanent dead link] (1992)
  260. ^ Tonelli MR (December 2001). “The limits of evidence-based medicine”. Respir Care. 46 (12): 1435–40, discussion 1440–1. PMID 11728302.
  261. ^ American College of Surgeons Bulletin: Practice guidelines and liability implications Archived 2006-09-26 at the Wayback Machine
  262. ^ “House Bill 1493 2005-2006 Session – North Carolina General Assembly”. www2.ncleg.net.
  263. ^ Kessler, JM (Winter 2005). “Pharmacy Quality Assurance”. Journal of the North Carolina Association of Pharmacists.
  264. ^ Martínez Pérez, María; Vázquez González, Guillermo; Dafonte, Carlos (2016-07-28). “Safety and Traceability in Patient Healthcare through the Integration of RFID Technology for Intravenous Mixtures in the Prescription-Validation-Elaboration-Dispensation-Administration Circuit to Day Hospital Patients”. Sensors. 16 (8): 1188. Bibcode:2016Senso..16.1188M. doi:10.3390/s16081188. PMC 5017354. PMID 27483269.
  265. ^ Jump up to:a b c d e f g Lacey, Susan; Smith, Janis B.; Cox, Karen. Patient Safety and Quality: An Evidence-Based Handbook for Nurses (PDF). Agency for Healthcare Research and Quality. Archived (PDF) from the original on 2013-02-23. Retrieved 2014-12-06.
  266. ^ Institute of Medicine (2000). To Err is Human: Building a Safer Health System. Washington, DC: National Academies Press.
  267. ^ Kaushal, R; Bates, DW; et al. (2001). “Medication errors and adverse drug events in pediatric inpatients”. JAMA. 285 (16): 2114–20. doi:10.1001/jama.285.16.2114. PMID 11311101.
  268. ^ Miller, MR; Elixhauser, A; Zhan, C (June 2003). “Patient safety events during pediatric hospitalizations”. Pediatrics. 111 (6): 1358–66. doi:10.1542/peds.111.6.1358. PMID 12777553.
  269. ^ Slonim, AD; Pollack, MM (2005). “Integrating the Institute of Medicine’s six quality aims into pediatric critical care: Relevance and applications”. Pediatric Critical Care Medicine. 6 (3): 264–9. doi:10.1097/01.pcc.0000160592.87113.c6. PMID 15857522. S2CID 9065548.
  270. ^ Beal, AC; Co, JPT; et al. (Jan 2004). “Quality Measures for Children’s Health Care”. Pediatrics. 113 (1): 199–209. doi:10.1542/peds.113.S1.199. PMID 14702502. S2CID 31718016.
  271. ^ Woods, DM; Johnson, J; et al. (December 2005). “Anatomy of a patient safety event: Pediatric patient safety taxonomy”. Qual Saf Health Care. 14 (6): 422–7. doi:10.1136/qshc.2004.013573. PMC 1744098. PMID 16326788.
  272. ^ Pediatric Quality Indicators Overview. AHRQ Quality Indicators. Rockville, MD: Agency for Healthcare Research and Quality. February 2006. Archived from the original on 2010-05-27. Retrieved 2012-02-03.
  273. ^ Aiken, LH; Clarke, SP; et al. (Oct 2002). “Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction”. JAMA. 288 (16): 1987–93. doi:10.1001/jama.288.16.1987. PMID 12387650.
  274. ^ Needleman, J; Buerhaus, P; et al. (May 2002). “Nurse-staffing levels and the quality of care in hospitals”. The New England Journal of Medicine. 346 (22): 1715–22. doi:10.1056/nejmsa012247. PMID 12037152.
  275. ^ Lamagne, P; McPhee, M (2004). “Troubleshooting pediatric peripheral IVs: Phlebitis and infiltration”. Nurs Spectrum. 8 (13): 18–20.
  276. ^ Infusion Nursing Society (2000). “Infusion nursing standards of practice”. J Intraven Nurs. 23 (6 Suppl): S1–85.
  277. ^ Rogers, Hwang, Scott, Aiken, Dinges, Ann E., Wei-Ting, Linda D., Linda H., David F. (2004). “The Working Hours Of Hospital Staff Nurses And Patient Safety”. Health Affairs. 23 (4): 202–212. doi:10.1377/hlthaff.23.4.202. PMID 15318582.
  278. ^ Scott, Linda D.; Rogers, Ann E.; Hwang, Wei-Ting; Zhang, Yawei (2006-01-01). “Effects of Critical Care Nurses’ Work Hours on Vigilance and Patients’ Safety”. American Journal of Critical Care. 15 (1): 30–37. doi:10.4037/ajcc2006.15.1.30. PMID 16391312. Archived from the original on 2016-11-17. Retrieved 1 April 2016.
  279. ^ Committee on the Work Environment for Nurses and Patient Safety, Board of Health Care Services, Institute of Medicine (Feb 27, 2004). Page, Ann (ed.). Keeping Patients Safe: Transforming the Work Environment of Nurses. National Academics Press. p. 12. ISBN 978-0-309-18736-7.
  280. ^ Scott, Rogers, Hwang, Zhang, Linda D., Ann E., Wei-Ting, Yawei (2006-01-01). “Effects of Critical Care Nurses’ Work Hours on Vigilance and Patients’ Safety”. American Journal of Critical Care. 15 (1): 30–37. doi:10.4037/ajcc2006.15.1.30. PMID 16391312. Archived from the original on 2016-11-17. Retrieved 1 April 2016.
  281. ^ Dorrian, Jillian; Lamond, Nicole; van den Heuvei, Cameron; Pincombe, Jan; Rogers, Ann E.; Dawson, Drew (7 July 2009). “A Pilot Study of the Safety Implications of Australian Nurses’ Sleep and Work Hours”. Chronobiology International: The Journal of Biological and Medical Rhythm Research. 23 (6): 1149–1163. doi:10.1080/07420520601059615. PMID 17190702. S2CID 27458281.
  282. ^ Dean, Grace E.; Scott, Linda D.; Rogers, ANN E. (2006). “INFANTS AT RISK: WHEN NURSE FATIGUE JEOPARDIZES QUALITY CARE: Advances in Neonatal Care”. Advances in Neonatal Care. 6 (3): 120–126. doi:10.1016/j.adnc.2006.02.001. PMID 16750806.
  283. ^ Williams, MV (1995). “Inadequate functional health literacy among patients at two public hospitals”. JAMA. 274 (21): 677–82. doi:10.1001/jama.274.21.1677. PMID 7474271.
  284. ^ The Institute of Medicine: Health Literacy: A Prescription to End Confusion Archived 2006-12-09 at the Wayback Machine (2004)
  285. ^ Davis, TC; Wolf, MS; Bass, PF III; Thompson, JA; et al. (29 November 2006). “Literacy and Misunderstanding Prescription Drug Labels”. Annals of Internal Medicine. 145 (12): 0000605–200612190–00144. doi:10.7326/0003-4819-145-12-200612190-00144. PMID 17135578. Archived from the original on 2007-02-24. Retrieved 2006-11-30.
  286. ^ U.S. Department of Health and Human Services: Quick Guide to Health Literacy Archived 2006-06-25 at the Wayback Machine
  287. ^ Williams, MV (1995). “The test of functional health literacy in adults: A new instrument for measuring patients’ literacy skills”. J Gen Intern Med. 10 (1): 537–41. doi:10.1007/BF02599568. PMID 8576769. S2CID 29005114.
  288. ^ Jump up to:a b The Commonwealth Fund: Five Years After “To Err Is Human”: What Have We Learned? Archived 2006-10-04 at the Wayback Machine
  289. ^ Rosenthal, MB; Frank, RG; Li, Z; Epstein, AM (2005). “Early experience with pay-for-performance: From concept to practice”. JAMA. 294 (14): 1788–93. doi:10.1001/jama.294.14.1788. PMID 16219882.
  290. ^ Petersen, LA; Woodard, LD; Urech, T; Daw, C; et al. (15 August 2006). “Does pay-for-performance improve the quality of health care?”. Annals of Internal Medicine. 145 (4): 265–272. doi:10.7326/0003-4819-145-4-200608150-00006. PMID 16908917.
  291. ^ Rosenthal, MB; Frank, RG (2006). “What Is the empirical basis for paying for quality in health care?”. Medical Care Research and Review. 63 (2): 135–57. doi:10.1177/1077558705285291. PMID 16595409. S2CID 8509605. Archived from the original on 2006-07-12. Retrieved 2006-07-09.
  292. ^ US Congress, House Committee on Employer-Employee Relations: Pay For Performance Measures and Other Trends in Employer Sponsored Healthcare, “Testimony of Meredith B. Rosenthal, PhD” (PDF). Archived from the original (PDF) on 2006-05-31. Retrieved 2006-07-09. (31.5 KiB) May 17, 2005
  293. ^ Medicare Australia: Practice Incentives Program (PIP) Archived 2009-06-12 at the Wayback Machine, Retrieved 2008-07-18
  294. ^ Pink, GH; Brown, AD; Studer, ML; Reiter, KL; et al. (2006). “Pay-for-performance in publicly financed healthcare: Some international experience and considerations for Canada”. Healthcare Papers. 6 (4): 8–26. doi:10.12927/hcpap.2006.18260. PMID 16825853., Retrieved 2008-07-18
  295. ^ Greß, S; Focke, A; Hessel, F; Wasem, J (2006). “Financial incentives for disease management programmes and integrated care in German social health insurance”. Health Policy. 78 (2–3): 295–305. doi:10.1016/j.healthpol.2005.11.011. PMID 16343688., Retrieved 2008-07-18
  296. ^ Custers, T; Arah, OA; Klazinga, NS (2007). “Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system”. Health Policy. 82 (2): 226–39. doi:10.1016/j.healthpol.2006.09.005. PMID 17070956., Retrieved 2008-07-18
  297. ^ Perkins, R; Seddon, M (2006). “Quality improvement in New Zealand healthcare. Part 5: measurement for monitoring and controlling performance—the quest for external accountability”. New Zealand Medical Journal. 119 (1241): U2149. PMID 16964301. Archived from the original on 2008-10-12. Retrieved 2008-07-18., Retrieved 2008-07-18
  298. ^ Jump up to:a b National Health Service: Quality and Outcomes Framework data Archived 2006-07-11 at the Wayback Machine Retrieved July 8, 2006
  299. ^ Rosenthal, MB; Frank, RG; Li, Z; Epstein, AM (2005). “Early experience with pay-for-performance, from concept to practice”. JAMA. 294 (14): 1788–93. doi:10.1001/jama.294.14.1788. PMID 16219882., Retrieved 2008-07-18
  300. ^ Doran, T; Fullwood, C; et al. (2006). “Pay-for-performance programs in family practices in the United Kingdom”. N. Engl. J. Med. 355 (4): 375–84. doi:10.1056/NEJMsa055505. PMID 16870916. S2CID 22548030.
  301. ^ Doran, T; Fullwood, C; Reeves, D; Gravelle, H; et al. (2008). “Exclusion of patients from pay-for-performance targets by English physicians”. The New England Journal of Medicine. 359 (3): 274–84. doi:10.1056/NEJMsa0800310. PMID 18635432. Retrieved 2008-07-18
  302. ^ Centers for Medicare and Medicaid Services. “Pay For Performance (P4P) Initiatives” (Press release).
  303. ^ Centers for Medicare and Medicaid Services. “Medicare Begins Performance-Based Payments For Physician Groups” (Press release). Archived from the original on 2007-04-08. Retrieved 2007-04-15.
  304. ^ Centers for Medicare and Medicaid Services. “First Evaluation Report to Congress” (PDF). Medicare Physician Group Practice Demonstration. Archived from the original (PDF) on 2008-10-08. Retrieved 2007-04-15.
  305. ^ Lindenauer, PK; Remus, D; et al. (2007). “Public reporting and pay for performance in hospital quality improvement”. The New England Journal of Medicine. 356 (5): 486–96. CiteSeerX 10.1.1.535.5131. doi:10.1056/NEJMsa064964. PMID 17259444.
  306. ^ Epstein, AM (2007). “Pay for performance at the tipping point”. The New England Journal of Medicine. 356 (5): 515–7. doi:10.1056/NEJMe078002. PMID 17259445.
  307. ^ Welker, JA; Huston, M; McCue, JD (2008-02-25). “Antibiotic timing and errors in diagnosing pneumonia”. Archives of Internal Medicine. 168 (4): 347–8. doi:10.1001/archinternmed.2007.84. PMID 18299488.
  308. ^ National Quality Forum (2007). Serious Reportable Events in Healthcare 2006 Update: A Consensus Report. Washington, D.C.: National Quality Forum. ISBN 978-1-933875-08-8. Archived from the original on 2007-08-29. Retrieved 2007-08-26. Retrieved 2007-08-25
  309. ^ Centers for Medicare & Medicaid Services (CMS) (2006-05-18). “Eliminating serious, preventable, and costly medical error – Never Events” (Press release). Archived from the original on 2007-05-13. Retrieved 2007-08-25.
  310. ^ “Medicare won’t pay for hospital mistakes”. The Washington Post. Associated Press. 2007-08-18. Archived from the original on 2015-08-26. Retrieved 2007-08-25.
  311. ^ Yee, Chen May (2007-08-22). “Medicare tightening the screws on medical mistakes”. The Minneapolis Star Tribune. Archived from the original on 2007-08-25. Retrieved 2007-08-26. Retrieved 2007-08-25
  312. ^ The Leapfrog Group (2006-11-15). “Call to Hospitals to Commit to New Policy on “Never Events”” (PDF) (Press release). Archived from the original (PDF) on 2007-09-27. Retrieved 2007-08-25.
  313. ^ IDSA; SHEA; APIC (2006-06-13). “Comment on CMS Inpatient PPS Proposed Rule 1488P: Healthcare-associated infection”. Archived from the original on 2006-07-12.
  314. ^ American Academy of Neurology. “Pay-For-Performance” (PDF). Federal Legislation Position Statements. Archived from the original (PDF) on 2006-10-18. Retrieved 2007-04-15.
  315. ^ Pham, HH; Schrag, D; O’Malley, AS; Wu, B; et al. (2007). “Care patterns in Medicare and their implications for pay for performance”. The New England Journal of Medicine. 356 (11): 1130–9. CiteSeerX 10.1.1.622.7686. doi:10.1056/NEJMsa063979. PMID 17360991.
  316. ^ Jump up to:a b Snyder, L; Neubauer, RL; American College of Physicians Ethics, Professionalism and Human Rights Committee (4 December 2007). “Pay-for-performance principles that promote patient-centered care: An ethics manifesto”. Annals of Internal Medicine. 147 (11): 792–4. doi:10.7326/0003-4819-147-11-200712040-00011. PMID 18056664. S2CID 26239771.
  317. ^ Leichter, SB (2006). “Pay-for-performance contracts in diabetes care” (PDF). Clinical Diabetes. 24 (2): 56–59. CiteSeerX 10.1.1.601.4675. doi:10.2337/diaclin.24.2.56. Archived (PDF) from the original on 2008-12-17. Retrieved 2008-03-31.
  318. ^ Cannon, Michael F. (2006). “Pay for Performance: Is Medicare a Good Candidate?” (PDF). Yale Journal of Health Policy, Law, and Ethics. 7 (1). Cato Institute: 1–38. PMID 17338285. Archived (PDF) from the original on 2008-04-09. Retrieved 2008-04-02..
  319. ^ “Danish Act on Patient Safety” (PDF). Archived from the original (PDF) on 2007-06-09.
  320. ^ Danish National Board of Health. “Danish Patient Safety Database 2007” (PDF).[permanent dead link]
  321. ^ “Strategy”. National Confidential Enquiries. Archived from the original on 2007-09-29. Retrieved 2006-07-02.
  322. ^ Institute of Medicine (1999). “Recommendation 5.1: Mandatory Reporting”. To Err is Human. Archived from the original on 2006-09-13.
  323. ^ Anesthesia Patient Safety Foundation (February 2000). “Response to the IOM Report”. Archived from the original on 2005-12-31.
  324. ^ Agency for Healthcare Research and Quality: Reporting Requirements Cloud Consensus on Curbing Medical Errors Archived 2006-08-29 at the Wayback Machine (May 2000)
  325. ^ 109th US Congress (2005-07-29). “Patient Safety and Quality Improvement Act of 2005”. Archived from the original on 2006-06-06.
  326. ^ Gaul, Gilbert M. (2005-07-29). “Plan would compile, analyze medical errors”. The Washington Post. p. A06. Archived from the original on 2016-03-04. Retrieved 2017-09-07.
  327. ^ “Lex Maria”. Health and Social Care Inspectorate (IVO) (in Swedish).
  328. ^ Ridelberg, Mikaela; Roback, Kerstin; Nilsen, Per; Carlfjord, Siw (21 March 2016). “Patient safety work in Sweden: quantitative and qualitative analysis of annual patient safety reports”. BMC Health Services Research. 16: 98. doi:10.1186/s12913-016-1350-5. ISSN 1472-6963. PMC 4802598. PMID 27001079.
  329. ^ US Agency for Healthcare Research & Quality: Beyond State Reporting: Medical Errors and Patient Safety Issues Archived 2008-04-24 at the Wayback Machine (Accessed 2008-03-23)
  330. ^ Hingorani, M; Wong, T; Vafidis, G (1999-03-06). “Patients’ and doctors’ attitudes to amount of information given after unintended injury during treatment: Cross sectional, questionnaire survey”. British Medical Journal. 318 (7184): 640–641. doi:10.1136/bmj.318.7184.640. PMC 27769. PMID 10066205.
  331. ^ Jump up to:a b Fung, CH; Lim, Y-W; Mattke, S; Damberg, C; et al. (2008-01-15). “The evidence that publishing patient care performance data emproves quality of care”. Annals of Internal Medicine (systematic review). 148 (2): 111–23. CiteSeerX 10.1.1.691.1541. doi:10.7326/0003-4819-148-2-200801150-00006. PMID 18195336. S2CID 43037926.
  332. ^ Hibbard, JH; Stockard, J; Tusler, M (2003). “Does publicizing hospital performance stimulate quality improvement efforts?”. Health Aff (Millwood). 22 (2): 84–94. doi:10.1377/hlthaff.22.2.84. PMID 12674410.
  333. ^ Serteser, Mustafa; Coskun, Abdurrahman; Inal, Tamer C.; Unsal, Ibrahim (2012-10-01). “How ISO-15189 laboratory accreditation assures patient safety? / Kako ISO-15189 akreditacija laboratorija osigurava bezbednost pacijenta?”. Journal of Medical Biochemistry. 31 (4): 271–280. doi:10.2478/v10011-012-0017-y. ISSN 1452-8266.
  334. ^ Joint Commission on Accreditation of Healthcare Organizations: 2006 Comprehensive Accreditation Manual for Hospitals: The Official Handbook. Oakbrook Terrace, IL: Joint Commission Resources, 2005
  335. ^ American Medical Association: Code of Ethics Archived 2007-09-29 at the Wayback Machine
  336. ^ Medical News Today: Sens. Rodham Clinton, Obama Propose National Medical Error Disclosure Program, USA Archived 2005-11-30 at the Wayback Machine (29 September 2005)
  337. ^ SorryWorks! Coalition: List of US states with apology laws Archived 2008-05-10 at the Wayback Machine (accessed 2008-05-18)
  338. ^ Massachusetts (ALM GL ch.233, 23D), California (Cal. Evid. Code section 1160), Florida (Fla. Stat. section 90.4026), Texas (Tex. Civ. Practice & Remedies Code section 18.0612), Washington (RCWA section 5.66.010), Oregon (2003 Oregon Laws Ch. 384), and Colorado (Colorado Revised Statute 13-25-135)
  339. ^ Jump up to:a b c Sack, Kevin (2008-05-18). “Doctors Start to Say ‘I’m Sorry’ Long Before ‘See You in Court'”. The New York Times. Archived from the original on 2015-06-13. Retrieved 2017-02-19.
  340. ^ “Making patient safety the centerpiece of medical liability reform”. N. Engl. J. Med. 354 (21): 2205–8. 2006. doi:10.1056/NEJMp068100. PMID 16723612. S2CID 28398606. {{cite journal}}: Unknown parameter |authors= ignored (help)
  341. ^ The National Medical Error Disclosure and Compensation (MEDiC) Bill did not receive subcommittee approval in 2005. Clinton included the proposal in her presidential campaign platform but has not resubmitted the bill to Congress.(see NY Times article) Archived 2015-06-13 at the Wayback Machine
  342. ^ “John M. Eisenberg Patient Safety Awards. Advocacy: the Lexington Veterans Affairs Medical Center”. Jt Comm J Qual Improv. 28 (12): 646–50. December 2002. doi:10.1016/s1070-3241(02)28069-4. PMID 12481598. {{cite journal}}: Unknown parameter |authors= ignored (help)
  343. ^ “Study Suggests Medical Errors Now Third Leading Cause of Death in the U.S. – 05/03/2016”. Archived from the original on 2017-03-03. Retrieved 2017-03-02.
  344. ^ Consumer-Purchaser Disclosure Project: Consumers, Purchasers, Physicians, and Insurers Agree on Principles to Guide Physician Performance Reporting (2008-04-01) News Release Archived 2008-04-01 at the Wayback Machine
  345. ^ Whistleblowing.org [1] Archived 2008-05-11 at the Wayback Machine Retrieved on 2008-03-17
  346. ^ UK Department of Health: News Release (1999-09-01): Government Moves To Halt Secrecy In NHS Retrieved 2008-03-17
  347. ^ Naomi Craft (1995). “Medicine and books: Whistleblowing in the Health Service: Accountability, Law and Professional Practice; Whistleblowing: Subversion or Corporate Citizenship?”. British Medical Journal. 311 (7017): 1444. doi:10.1136/bmj.311.7017.1444. S2CID 58688841. Archived from the original on 2003-08-25. Retrieved 2008-03-17.
  348. ^ AHRQ: 2006 National Healthcare Quality Report Archived 2007-02-06 at the Wayback Machine Retrieved 2007-01-12
  349. ^ “Many patients with advanced cancers get treatments that won’t help, study finds”. ScienceDaily. Archived from the original on 2018-11-18. Retrieved 2018-03-09.
Translate »
× How can I help you?